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Abstract 
The lens is a transparent, biconvex structure located between the iris and the vitreous humour. It is bathed 
by aqueous humour anterior to the lens, which plays a role in nutrient transport into the lens as it is 
avascular. The outermost layer of the lens consists of a single layer of epithelial cells. These cells elongate 
and differentiate into lenticular fibres which are laid down in concentric layers to form the mass of the lens. 
Mature fibre cells lose all their organelles to maintain lens transparency, thus there is no lipid or protein 
turnover in the lens nucleus. The lens is first formed in utero and continues to grow throughout a human’s 
lifespan. The lens formed before birth is referred to as the lens core, where the cells that were laid down 
immediately after birth (infantile nucleus) are referred to as the inner region. Tissue formed during 
childhood years make up the first layers of lens cortex outside the nucleus, while cells laid down after 
middle age are referred to as the outer region. The formation of the barrier between the inner cortex and 
nucleus at middle age reduces the diffusion of antioxidants and water into the nucleus, as a consequence of 
the occlusion of membrane pores. Alterations to the membrane lipid composition has the ability to alter the 
water permeability of aquaporin-0 and also render the membrane more adhesive to α-crystallins, which may 
reduce water permeability and also cause greater pore occlusion. As a consequence, the lens is more 
susceptible to protein precipitation and oxidation, leading to age-related nuclear cataract. Experimental 
evidence suggests that the lipid profile of the lens core changes dramatically around the age of 40, 
coinciding with the formation of the barrier region. It has been observed that lens sphingomyelin and 
dihydrosphingomyelin form an annular distribution within the barrier region in an adult lens, while 
ceramide and dihydroceramide levels that were negligible in the core of young lenses have a sharp increase 
in abundance after the age of 40. These studies indicate that the change in lipid profile may be related the 
barrier formation with middle age. 
In this thesis, methods to optimise mass spectrometric imaging of human lens tissue were developed. It was 
found that sublimation of matrix was the fastest way to apply a layer of homogenous matrix that was optimal 
for matrix-assisted laser desorption ionisation (MALDI) imaging. Sublimation conditions were fined tuned 
for 2-Mercaptobenzothiazole to be used as the matrix in positive ion mode and 2,5-diaminonapthalene to 
be used as the matrix in negative ion mode. 
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Following the development of MALDI imaging of human lenses, the distribution of lens lipids was 
investigated. Many recently identified sphingolipids and also complex glycosphingolipids were mapped for 
the first time in the adult human lens. It was observed that certain sphingolipids only localise in certain 
regions of the lens. For example, sulfatides were only observed in the cortex and not the nucleus. In contrast, 
ceramides and dihydrolactosylceramides were localised to the lens nucleus. The difference in distribution 
for each lipid class raises questions as to the role of these lipids within the human lens. Distribution images 
of glycerophospholipids were also obtained in this study. Most phospholipid classes were present in the 
cortex except for lysohosphatidylethanolamine. Phosphatidic acid species which has only been recently 
detected in the lens were imaged for the first time. They were found to be distributed around the cortex of 
the lens. Combining these data, the spatial information for most of the lipids identified to-date in the human 
lens were obtained. 
Lipids were also quantified in each region of the lens over the human lifespan. It was revealed that the lipid 
composition is different in each lens region, for example, glycerophospholipids were found to have a higher 
abundance in the lens cortex, while sphingolipids were found to have a higher abundance in the lens 
nucleus. Some lipid classes did not show significant changes with age whilst of those that did, 
glycerophospholipids decreased in concentration with age and sphingolipids increased in concentration 
with age. There is a sudden increase in ceramide and dihydroceramide levels in the nucleus after the age of 
40 as previously observed, however this change also occurs in the cortex. It was also identified that age-
related alterations in lipid abundances are most prevalent in the barrier region of the human lens. 
In conclusion, this thesis has developed a method for the imaging of lens lipids and studied the distribution 
and abundance of a range of lipid classes in different regions of the lens. Middle age appears to be a key 
transition point for changes in lipid composition, with major changes to the lipid composition occurring 
around this time in all regions of the lens. This coincides with previously reported macroscopic changes 
occurring at approximately age 40. The alterations to the majority of lipid classes in the barrier also suggest 
that the barrier region is more prone to age-related effects compared to other regions. The lens is a unique 
model which allows us to study the effect of ageing on lipid composition and the change in lipid 
composition of long-lived and newer fibre cells. 
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Chapter 1: Introduction 
1.1 The Lens 
The human eye enables vision through the detection and transduction of light. It has two regions: an optical 
region which gathers and focuses light to form an image; and a neural region (retina) where the image is 
then converted into an electrical signal for the primary visual cortex to interpret. The lens is a transparent 
tissue located in the anterior chamber of the eye, between the iris and the vitreous body. It is enclosed within 
an elastic capsule and is suspended by zonular fibres that extend from the ciliary body. As an avascular 
structure, the lens must obtain nutrients from the aqueous humour that bathes the anterior surface of the 
lens.1, 2 The lens develops continuously throughout a person’s life beginning at the embryonic phase. Its 
development starts from the epithelium that consists of a layer of cuboidal cells. Posterior epithelial cells 
in the lens vesicle elongate and form primary fibre cells, which are arranged in tightly packed concentric 
layers (Figure 1.1).3, 4 These primary lens fibre cells are the shortest mature fibres in the lens.5 
 
Figure 1.1: A transverse section of the human lens. Figure taken from Harding (2002).2 
The differentiation of anterior epithelium fibre cells at the lens equator is followed by a subsequent loss of 
nuclei and other intracellular organelles.6, 7 This process maintains lens transparency and prevents light 
scattering. Epithelial cells at the germinative zone elongate and differentiate to stack on top of pre-existing 
fibre cells, known as secondary fibre cells.7 Fibre cells are never lost or replaced from the lens, thus it grows 
in size throughout a person’s life.5 The lens at birth, which consists of the primary cells in the centre is 
known as the nucleus; while the cortex refers to cells that are laid down thereafter.  
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The lens fibre cells are interconnected by gap junctions and an anterior layer of single cuboidal cells at the 
lens surface known as epithelial cells.8 These gap junctions allow metabolic co-operation of small 
molecules through the intercellular diffusion of ions, metabolites and water.8 They are formed by a family 
of integral membrane channel-forming proteins called connexins.8, 9 The transport properties in the lens 
differs in three zones. The epithelial cells express most of the active transport proteins in the lens, where 
the mature fibers, which lack organelles express membrane transporters for nutrients and antioxidants that 
are needed for homeostasis.9 The differentiating fibers, which still have organelles, have different 
membrane transporters than the epithelium.9 Early study of the lens microcirculation system found that the 
lens current densities at the surface of a free-standing lens were surprisingly large and were not directed 
across the lens.10 In fact, they were inward in the region of either the anterior or posterior pole and outward 
at the equator (as shown in Figure 1.2).11 This is the most dramatic physiological property of a normal lens 
and is believed to maintain the lens clarity.10 
 
Figure 1.2:  Cross section of a mouse lens. The circulation of ions and fluid (depicted in green) follows the 
pattern indicated by the arrowheads: ions and fluid enter extracellular spaces of the lens at the anterior 
and posterior poles and they exit across epithelial cell membranes at the equator.11 
 
In this thesis, lenses are discussed based on the dissected four regions, which are the outer, barrier, inner 
and core (Figure 1.3). Anatomically, the cortex region includes the outer and the barrier region, whereas 
the nucleus includes the inner and core regions. The outer region solely contains the cortex cells, which is 
comprised of both fibre cells and epithelial cells. These cells are still metabolically active. The barrier refers 
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to the region within the inner boundary of the cortex, which corresponds to lens fibre cells that were laid 
down during childhood years.12-14 This region develops into a functional barrier to the lens nucleus around 
the age of 40 as described by Sweeney and Truscott14 as opposed to the anatomical barrier, which is 
described by Donaldson and Lim.15, 16 Changes to the protein and lipid composition in the barrier with age 
have been implicated in the development of age-related nuclear cataract.14 The formation of a barrier retards 
the diffusion of antioxidants from the cortex into the lens centre, leaving it prone to oxidative 
modification.17 The core is sectioned so that it only contains in utero nuclear cells, thus this region can be 
used for true age-related comparisons. The inner region is comprised of the remaining nuclear fibre cells 
but may also contain some early cortical cells laid down shortly after birth.  
 
Figure 1.3: Illustration of the four regions of human lens obtained by dissection.18 
Energy production in the lens is dependent on anaerobic glycolysis, as the lens loses most of its organelles, 
including mitochondria, during differentiation.3 The mature fibre cells in the lens centre therefore undergo 
little or no metabolic activity.19-21 Most of the lipids in the lens are membrane lipids, which function as 
channels for diffusion.8 Therefore, the lens nuclear cells rely on the efficient transport of gluthatione from 
the outer cortex and epithelium via diffusion through pores.14 
1.2 Lens Membrane 
Biological cellular membranes are composed of lipids, proteins and carbohydrates. They serve as selective 
barriers that regulate the entry and exit of substances into and out of the cell and provide an active surface 
for biochemical reactions to occur. Membrane proteins have many roles, they may function as ion channels 
or pumps that control the exchange of solutes; or act as energy transducers, enzymes or receptors for 
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transmembrane signalling.22, 23 Phospholipids, glycolipids and cholesterol are the main lipids forming the 
membrane bilayer. These lipids function as signalling molecules, anchors for membrane proteins, and create 
a semi-permeable bilayer that preserves electrochemical gradients.22-24 
Figure 1.4 shows the differences between the fluid mosaic model as proposed in 1972 by Singer and 
Nicholson,25 and the lens membrane proposed by Borchman et al. in 2010.26 Transmembrane proteins in 
the typical membrane float in a fluid bilayer of phospholipids and glycolipids, with a low abundance of 
cholesterol packing in between the phospholipids to facilitate order in the membrane.26 Phospholipids in 
the typical membrane are of a variety of classes, head groups and fatty acyl chains, and the degree of 
unsaturation of the fatty acyl chain is a key factor in regulating membrane fluidity. 
 
Figure 1.4: A comparison of the typical membrane proposed by Singer and Nicholson and lens membrane 
proposed by Borchman.26  
The human lens membrane has a unique lipid profile compared to other mammalian lenses and other human 
tissues.27 The human lens has one of the most saturated and ordered membranes in the human body owing 
to the lipids that are present.26 It has the highest abundance of dihydrosphingomyelin (DHSM), comprising 
47% of total human lens phospholipid, and 72% of total sphingolipid (SL) in the human lens.27-29 This is in 
contrast to other animal lenses where DHSM is less than 3% of total phospholipid.27 It is suggested that 
humans have adapted to the higher SL content in order to maintain membrane stability over our extended 
lifespan.26, 30 Other long-lived animals, such as camels, rarely develop cataract in old age, despite living in 
adverse conditions. It has been shown that camel lenses are comprised of 77% SL.30 In addition to the high 
abundance of DHSM, human lens membranes also contain a high level of cholesterol. The molar ratio of 
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cholesterol to phospholipid in the human lens ranges from 2-6 in comparison to the plasma membrane 
which is about 0.52-0.70.31-34 In fact, there is enough cholesterol in a human lens membrane to aggregate 
and form pure cholesterol domains.35, 36 Cholesterol domains are pure bilayers of cholesterol, which differ 
from lipid rafts that consist of laterally associated sphingolipids with cholesterol filling the space between 
the sphingolipids.36 Moreover, lipid rafts are involved in signalling,33, 37, 38 while no such role has been 
identified for cholesterol domains. In the raft regions of the lens, cholesterol preferably associates with 
DHSM as it is more abundant than SM and has a stronger binding affinity to cholesterol.39  
The high abundance of cholesterol and DHSM in the lens membrane may be essential for maintaining lens 
function. The highly saturated and stable DHSM may prevent oxidation in the lens membrane.39 Studies 
have also shown that the inhibition of cholesterol synthesis in animal lens causes cataract40 and cholesterol 
clusters were absent in cataractous human lens.33   
1.3 Lens Lipids 
Besides cholesterol, the main component of the lens membrane are phospholipids. Phospholipids contain a 
hydrophilic headgroup, which interacts with the cytoplasm or the extracellular environment and two fatty 
acyl chains which contribute to the hydrophobic region of a membrane lipid bilayer.41 Different head groups 
and the length and degree of unsaturation of the fatty acyl chain can affect physical properties such as 
membrane fluidity.41 Similarly to lens proteins, lens membrane lipids do not turn over42, 43 and therefore, 
need to be able to resist oxidation and degradation throughout a human’s lifespan.43 
1.3.1 Fatty Acids 
Fatty acids are carboxylic acids with a long hydrocarbon chain. They are the major building blocks of 
complex lipids found in membranes. Fatty acids are mostly esterified to phospholipids, cholesterol esters 
and sphingolipids. In the lens, systemic fatty acids are transported into fibre cells by albumin in the aqueous 
humour.44-46 Fatty acids can vary in the number of carbons in the chain, and the number, position and 
stereochemistry of the double bonds. The two most abundant fatty acyl chains in the human lens are palmitic 
and nervonic acid.27, 32 
The stereochemistry of the double bonds is often described first, with cis (Z) representing both substituents 
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on the same side of the bond, in comparison to the trans (E) conformation where the substituents are located 
on opposite sides. Generally, fatty acids are described by i) the hydrocarbon chain length; ii) the number of 
double bonds; iii) the location of the double bonds and iv) the stereochemistry of their double bonds.47, 48 
The nomenclature of fatty acids is illustrated in Figure 1.5. For example, a 24-carbon fatty acyl chain with 
a cis configuration at the 15th carbon is named as FA 24:1(15Z). If the position and stereochemistry of the 
double bond is unknown, as is the case with conventional mass spectrometry, then this lipid is described as 
24:1. When present in a molecular lipid, e.g. DHSM with a 24:1 fatty acyl chain it is written as 
SM(d18:1/24:1), where 1 is the number of double bonds present in the fatty acyl chain. 
 
Figure 1.5: Structural differences between cis and trans geometry of nervonic acid (common name), also 
known as 15-tetracosenoic acid (systematic name). (A) is FA 24:1(15Z) as for cis configuration, the 
numbering shows the location of the double bond from the terminal -COOH group.  (B) is FA 24:1(9E) as 
for trans configuration the numbering shows the location of the double bond from the terminal methyl 
group.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
1.3.2 Lens Glycerophospholipids  
Glycerophospholipids (GPs) consist of a 3-carbon glycerol backbone with two fatty acids at the sn-1 and 
sn-2 positions and a phosphate head group attached at the sn-3 position (Figure 1.7). There are four main 
classes of GP present in the human lens: phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS) and phosphatidic acid (PA) as shown in Figure 1.7.27 GPs are named according to 
the fatty acyl chains and the head group, for example: phosphatidylcholine with 16:0 and 18:1 fatty acyl 
chains attached at the sn-1 and sn-2 positions respectively, is named PC (16:0/18:1).47, 48 In most tandem 
mass spectrometry experiments sn-position cannot be determined, therefore it is written as PC (16:0/18:1). 
In addition to the ester linkage of fatty acyl chains to the glycerol backbone, they can be also bound via an 
FA 24:1(15Z) 
FA 24:1(9E) 
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1-O-alkyl ether or 1-O-alkenyl ether linkage at the sn-1 position (Figure 1.6). In the human lens, two thirds 
of phosphatidylethanolamine and phosphatidylserine are 1-O-alkyl ether-linked.27, 29, 49  
 
 
Figure 1.6: The general structure of glycerophospholipids. HG: head group; R1 acyl chain at the sn-1 
position; R2 acyl chain at the sn-2 position; sn: stereospecific numbering. 
 
Figure 1.7: A schematic illustration of glycerophospholipids. R1 and R2 represent the fatty acyl chains at 
the sn-1 and sn-2 positions, respectively. X corresponds to the headgroup moiety linked via an ester linkage 
at the sn-3 position. The abbreviation of phospholipid class is shown in brackets. 
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Phosphatidylcholine is the most abundant GP in animals lenses, which accounts for 31-46% of total 
phospholipids in rat, chicken, sheep, cow, and pig.27 On the other hand, PC only accounts for 11% of the 
total human lens phospholipidome.27 The most abundant GP in the human lens is 
phosphatidylethanolamine,27, 29, 50 the majority of which are 1-O-alkyl ether-linked.27, 49 These ether-linked 
phospholipids are believed to be associated with lens transparency, as the inhibition of their synthesis causes 
cataract in mice.51 Lyso-derivatives of GPs that possess only the sn-1 fatty acyl chain are also observed.27, 
49 
1.3.3 Lens Sphingolipids 
The main lipid classes present in the human lens belong to the sphingolipid family. These lipid classes 
contain either a sphinganine (d18:0) backbone, or the unsaturated sphingosine (d18:1) backbone with 18 
carbons and a trans double bond at the 4 position (see Figure 1.8).52 The “d” stands for “dihydroxy”, 
referring to the two hydroxyl groups present on the sphingoid backbones. Derivatives of the sphingosine 
backbones such as SM, ceramide (Cer) and ceramide-1-phosphate (CerP) have also been detected and 
quantified in older human lenses.53 SM contains a phosphocholine head group esterified to the sphingoid 
base. Examples of these structures are shown in Figure 1.8. The same names apply to those with the 
sphinganine backbone but with a prefix of “dihydro-”, which is abbreviated by “DH”. For example, 
ceramides with a sphinganine backbone can be referred as dihydroceramides, or DHCer.49, 54 The CerP or 
dihydroceramide phosphate (DHCerP) contain an extra phosphate group when compared to Cer or DHCer. 
Fatty acids are attached via an amide linkage at the 2nd carbon of the backbone, and the nomenclature used 
is similar to that used for GP. In the human lens, most of the sphingolipids are comprised of a sphinganine 
backbone with either a 16:0 or a 24:1 fatty acyl chain.12, 30, 55 For example, a SM with a 16:0 fatty acyl chain 
will be named SM (d18:1/16:0) whereas a DHSM with a 16 carbon saturated fatty acyl chain will be 
represented by SM (d18:0/16:0). 
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Figure 1.8: The structures of the sphingosine and sphinganine backbone and their derivatives. The two 
sphingoid backbones differ in the presence of trans-double bond between the 4th and 5th carbons. CerP 
and DHCerP contain an extra phosphate group in comparison with Cer and DHCer. A phosphocholine 
moiety is esterified at the sphingoid backbone for both SM and DHSM. Fatty acids are attached via an 
amide bond at the 2nd carbon. 
As shown in Figure 1.8 the de novo synthesis of SLs begins with the condensation of palmitoyl coenzyme A 
and serine, catalysed by serine palmitoyltransferase. The synthetic pathway of DHSM still remains unclear 
despite it being the most abundant SL in the lens. It is proposed by Michel et al. that it may be synthesised 
from DHCer through an unknown enzyme.56 However, a recent review by Merill has suggested that DHSM 
is synthesised from DHCer by sphingomyelin synthase.57 Other dihydroglycosphingolipids such as 
dihydrolactosylceramides (DHLacCer) may also be synthesised from DHCer, while glycosphingolipids, SM 
and CerP are derived from Cer.58, 59 A detailed description of sphingolipid synthesis is beyond the scope of 
this thesis however, further information regarding the synthetic pathways can be found in Futerman et al.59 
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Figure 1.9: The de novo synthetic pathway of SLs through to lactosylceramide and sulfatide. The enzymes 
involved in each step are shown in orange. SPT: serine palmitoyltransferase; CerS: ceramide synthase; 
SMS: sphingomyelin synthase; DES: dihydroceramide desaturase; GalCerS: galactosylceramide synthase; 
GlcCerS: glucosylceramide synthase; CERK: ceramide kinase; STS: sulfatide synthase; LacCerS: 
lactosylceramide synthase.                               
1.3.4 Lens Glycosphingolipids & Other Complex Gangliosides 
Glycosphingolipids (GSLs) refer to lipids containing either a sphingoid or ceramide moiety with one or 
more monosaccharide groups attached to the 1-hydroxyl position via a β-glycosidic linkage. The 
identification of this class of lipid in normal60-62 and cataractous55, 62, 63 human lenses has previously been 
reported. They can be subdivided into categories of neutral GSLs and acidic GSLs, depending on the 
properties of the groups that are attached to the lipid. For example, neutral GSLs are those with sugar groups 
attached, whereas acidic GSLs may have sialic acid or sulfate ester groups bound to them. Ariga et al. 
(1994) demonstrated that in cataractous lenses, the majority of GSLs contain the sphinganine backbone and 
the fatty acyl chain 16:0, 24:0 and 24:1, which follow the compositional trends of fatty acyl chains observed 
in other sphingolipid classes.55 Although the major fatty acyl chains in GSLs have been identified, they are 
not correlated with any specific, individual subcategory of GSLs. One such example is sulfatide (ST), which 
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is shown in Figure 1.10.  
 
Figure 1.10: The structure of SM3 (d18:1/24:1). It contains two sulfate head groups and a ceramide 
backbone with a 24:1 fatty acyl chain attached to the amide.   
We have recently developed methods to detect these low abundant species in the lens using mass 
spectrometry (MS). Direct coupling of ambient ionisation mass spectrometry techniques with thin-layer 
chromatogtraphy (TLC) has enabled the direct analysis of TLC plates without further sample preparation. 
These advances have been made possible by the development of desorption electrospray ionisation (DESI) 
by the Cooks group in 2004.64 In brief, DESI operates in the ambient environment by spraying charged 
micro-droplets from an emitter towards the sample surface, where analytes are desorbed into the gas phase 
and ionised, then extracted into the mass spectrometer for analysis.65 
Our previous work has illustrated that TLC-DESI-MS is a promising method to obtain qualitative data on 
the lens sphingolipidome.66 By combining TLC with DESI-MS, faint spots on the TLC plate or incomplete 
separation can be resolved by precise mass spectrometric analysis. With this technique, 30 species of SLs 
from 11 different classes were identified in a lipid extract from a 20 year-old human lens. The classes not 
only include DHSM, SM, Cer, DHCer, DHLacCer, CerP and DHCerP that have previously been reported;26, 
28, 67-69 but also several novel classes of lipids such as lactosyl ceramide sulfates (SM3), dihydrolactosyl 
ceramide sulfates (DHSM3), sulfatides (ST) and  dihydrosulfatides (DHST).66 Although these lipids were 
found at very low abundance in the lens,26 the structures of each molecule were able to be elucidated by 
collision-induced dissociation (CID). A negative ion mass spectrum obtained from the DHSM3 region of a 
TLC plate is shown in Figure 1.11(A). Like other SLs in the lens, the two most abundant analogues of 
DHSM3 contain a 16:0 or 24:1 fatty amide chain. The lipid structure is characterised by CID, which is 
shown in Figure 1.11B. 
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Figure 1.11: (A) Negative ion mass spectrum of a 20-year old human lens lipid extract DHSM3 region. (B) 
CID spectrum of SM3 (d18:0/24:1) at m/z 1052 with its proposed structure.66 
Although this lipid class is proposed to be less than 1% of the total human lens lipidome,28 GSLs are known 
to be essential for the differentiation and maturation of lens fibre cells.70 GSLs are often located at the 
exocytoplasmic leaflet of cell membranes, where their sugar moieties interact with other biomolecules in 
cellular differentiation and transformation.71 They are also involved in signal transduction in conjunction 
with lipid rafts.72 The physicochemical properties of lipid rafts in normal and cataractous lenses appear to 
be different, thus it is important to further elucidate the composition of these lipids in particular regions of 
the human lens.33 An increase in GSL abundance has also been observed with age and cataract,61, 62, 73 and 
is proposed to influence cell-to-cell interactions that initiate cataractogenesis.60 
1.4 Age-related Changes in the Lens 
Accommodation is the process whereby the lens adjusts its curvature to focus light upon the retina to 
observe near objects. Age is the major factor for the lens to lose its ability to accommodate. The lens is 
exposed to cumulative effects of oxidation, radiation and post-translational modifications with ageing, such 
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that proteins and other biomolecules in the lens are modified, leading to visual impairment.74 Previous work 
has also shown that there is a massive increase in lens stiffness with age, particularly in the nuclear region.75  
1.4.1 Changes in Proteins 
As there is no protein turnover in the human lens nucleus,42 these long-lived proteins are exposed to factors 
that can cause undesirable modifications that may lead to protein aggregation.76 The damaged proteins 
become insoluble and thus precipitate, causing opacification of the lens. The lens contains an abundance of 
α-crystallins, which act as chaperones, binding to proteins as they denature to maintain their solubility.76, 77 
This process is essential for maintaining the transparency of the lens. With age, more α-crystallins sequester 
the denatured protein to form high molecular weight complexes, causing free α-crystallins to decrease.77 
The depletion of chaperones causes the accumulation of denatured protein in the lens nucleus, which results 
in stiffening of the lens.77 α-crystallins binding to lens membrane proteins may lead to the formation of a 
barrier that reduces the diffusion of antioxidants into the lens centre, leaving the proteins and lipids 
vulnerable to oxidation and consequently cataract.78  
Aquaporin-0 is the most abundant integral membrane protein in fibre cells, which is responsible for water 
transport through its core.79 The association between aquaporin-0 and membrane phospholipids was 
observed in sheep lenses using X-ray crystallography.80 Lipids were found to form a one-molecule wide 
shell around the protein.80 Mutations in aquaporin-0 may prevent proper interactions between this protein 
and its surrounding lipids that could affect the folding and integration of membrane proteins into a bilayer.81  
In summary, the changes in lens proteins causes a reduction in the diffusion of water from the cortex to the 
lens nucleus as well as accumulation of high molecular weight aggregates and insoluble proteins. 
Consequently, the lens undergoes a gradual reduction in transparency, increase in stiffness and an increase 
in the scattering and aberration of light waves as well as a degradation of the optical quality of the eye 
which may lead to the onset of cataract.82 
1.4.2 Changes in Lipids 
The long lifespan of lipids in the lens membrane is likely to result in cumulative photo- and/or chemical 
oxidation despite the hypoxic environment in the lens.83 The association between lipid oxidation and lens 
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transparency with age suggests that lipid oxidation may initiate cataractogenesis.29, 84 More than 40% of 
phospholipids in the lens are degraded throughout a human’s lifespan, even more in the case of cataract, 
forming deleterious oxidation products.29, 68 The insertion of hydrophilic moieties into acyl chains as a result 
of oxidation can disrupt lipid-lipid interactions, causing structural abnormalities in the membrane.85  
Analysis of the lens lipid composition has revealed that the abundance of phospholipids and SLs in the lens 
nucleus changes as we age.53 GPs are abundant in the nucleus of young lenses, but decrease with age until 
40 years and then plateau at very low levels (Figure 1.12).53 Figure 1.12A shows that PC is reduced by 
approximately 75% by the age of 40 while Figure 1.12B shows that PS is reduced by 85% over the same 
period.53 PE, which is the second most abundant GP class in the lens, showed a similar trend with a 50-fold 
decrease in Figure 1.12C.53 Hughes et al. identified and quantified lysophosphatidylethanolamine (LPE), 
the most abundant GP class in the human lens nucleus. This lipid class showed a gradual decline in 
concentration with age.53 Other microscopic and macroscopic changes to the lens also occur around 40-50 
years of age. For example, presbyopia normally occurs around the age of 50.86, 87 This dramatic change in 
the membrane lipid composition may contribute to increased binding of crystallins and blockage of 
membrane pores in the lens, which could in turn disrupt intracellular transport promoting oxidation.18  
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Figure 1.12: Total concentration of (a) PC; (b) PS; (c) PE and (d) LPE present in the human lens nuclei 
from young to old lens.53 The solid line is a generalised additive model fit; the dashed lines provide a 95% 
confidence band. 
To date, glycosphingolipids identified in the human lens include DHLacCer, DHSM3, DHST55, 66, 67, 88 and 
other complex glycosphingolipids such as gangliosides which have a sialic acid moiety attached.55, 60, 62 
These GSLs were identified using whole lens lipid extracts and were not quantified except for the 
gangliosides. More recently, DHSM3 and DHST were identified in a whole lens homogenate, however, 
they were not quantified.47 Therefore, their distribution and concentration in the different regions of the 
lens remain unknown. Although the literature identifies the age of 40 as an age of transition in the lens 
nucleus,53 the reason for the increase of DHCer and Cer in the lens nucleus remains unknown. Therefore 
an investigation of age-related changes of these GSLs is crucial to determine if they contribute to the 
30 
 
increase in ceramides. It is also essential to study the changes of lipid composition in different regions of 
the lens such as the barrier and outer cortical regions, as these regions comprised of newer fibre cells that 
were synthesised post-natally. 
1.5 Mass Spectrometry Imaging 
Mass spectrometry imaging (MSI) has emerged as a complementary tool to study the distribution of specific 
biomolecules in tissue. MSI now allows for specificity in spatial localisation of anatomical structures, cells, 
stains and even biomolecules like lipids and proteins without labelling.89 MSI contains a number of different 
ionisation techniques whereby each technique requires a unique process to preserve the corresponding 
sample. Matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) is the most popular 
ionisation technique for MSI due to its capability to image a wide range of molecular weights and molecular 
species.90 However, its requirement of a matrix for proper ionisation and production of only singly-charged 
ions often limits its applicability to large proteins. There are also other varieties of MALDI-MSI such as 
scanning microprobe MALDI (SMALDI),91 infrared (IR)-matrix assisted laser desorption ESI 
(MALDESI)92 and surface-assisted laser desorption/ionisation (SALDI). 93 However, none of these 
techniques have been used for studying the occular lens and will not be discussed further. 
MALDI-MS has been widely used in understanding the cellular components of the eye. It has been applied 
to study the structure and function of normal ocular tissue, the molecular changes that are associated with 
the ageing eye and in pathological processes that lead to diseases of the eye, such as cataract and macular 
degeneration.89 These studies include the imaging of proteins and lipids in the retina,94-99 optic nerves97, 100, 
101 and lens.12, 69, 102-104  
In brief, in MALDI-MSI, thin tissue is mounted on a target, then coated with matrix before being analysed 
using a MALDI source. In the source, a laser is rastered across the tissue surface while mass spectra are 
collected at each sampling location. MALDI images are then obtained by plotting the intensity of an 
observed ion as a function of its sampling location. More details of MALDI-MSI can be found in Chapter 
2. 
On the other hand, DESI-MS was first reported for visualisation of brain lipids by Ifa et al. in 2012.105 The 
typical set up for DESI analysis is shown in Figure 1.3. In DESI, a pneumatically assisted electrospray is 
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directed at the surface of interest, causing charged droplets to impinge the surface.106 Analytes are then 
dissolved, generating secondary droplets that scatter off the surface and ionise for MS-analysis.64, 107 The 
advantage of DESI-MS over other methods of MSI are its ability to directly analyse surfaces under ambient 
conditions with minimal sample preparation and allowing the soft ionisation of biomolecules such as lipids 
and proteins at the same time.108 The spatial resolution of DESI is largely determined by the spray droplet 
diameter which is typically around 200-500 μm.107  
 
Figure 1.13: Typical experimental set up for DESI. 
1.5.1 Lens Protein Imaging 
The distribution of α-crystallins in the bovine lens were originally mapped using MALDI-MS by Han et 
al.109 Traditionally, immunohistochemistry is the preferred technique to profile protein distribution in a 
tissue. However, this technique requires antibodies to detect specific proteins and is usually limited to one 
protein at a time. This study highlighted the advantage of using MSI over an antibody-based strategy for 
mapping multiple post-translational truncations to a single protein. By using MALDI-MS, they were able 
to image bovine lens α-crystallins in its multiple forms in a single experiment.109  Further studies of 
crystallin imaging using animal lenses from rabbit and rodents were aimed at improving the spatial 
resolution,110 developing methods to map β- and γ-crystallins111, 112 and to investigate the changes to 
crystallins in age-related cataract.113 Human lens mapping of β- and γ-crystallin peptides were also studied 
in ageing and cataractous lenses.114-117 Grey and colleagues have developed a method to spatially map the 
age-related changes of human lens α-crystallins using MALDI-MS.114 The results showed that intact α-
Incident emitter-surface
angle
Collection angle
Short emitter
sample distance
MS inlet
Emitter
Solvent
kV
32 
 
crystallins (1-173) are most abundant in the cortex and also present in the nucleus of 7- and 29-year-old 
lenses (Figure 1.14). However, in 51- and 75-year-old lenses, intact α-crystallins were not detected in the 
lens nucleus. Application of this spatially resolved proteomic technique improves our understanding of lens 
protein modifications with age. 
 
Figure 1.14: MALDI tissue images of intact αA-crystallin (1-173) with age in equatorial human lens 
sections.1 
1.5.2 Lens Lipid Imaging 
Lens lipid imaging has been performed previously by DESI-MS and MALDI-MS. Ellis et al. used DESI-
MS to study the distribution of a wide range of lipids including CerP, PE, PS, LPE and cholesterol for the 
first time in the human lens.67 These images are shown in Figure 1.15. However, as the lens fibre cells are 
arranged in a tightly compacted structure, a strong acid needs to be added in the spray solvent in order to 
disrupt the physical structure of the tissue.67 This may compromise the spatial distribution of lens lipids. 
Although DESI-MS was able to provide distribution images of the lipids, its resolution of ~200μm is 
significantly lower than what standard MALDI-MS can provide (~50-100μm). 
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Figure 1.15: DESI images of a 41-year old human lens showing the distribution of (a) SM (d18:0/16:0); 
(b) PE (18:1e/18:1); (c) CerP (d18:0/16:0); (d) Cholesterol; (e) SM (d18:0/24:1); (f) PS (18:1e/18:1); (g) 
Cer (d18:0/16:0); (h) LPE (18:1e) by Ellis et al.67 
Lens lipid imaging has also been performed using MALDI-MS in human12, 118 and porcine69, 103 lenses. The 
initial MALDI-MSI analysis of porcine lens detected seven species of SM and two species of CerP.69 A 
further MALDI-MSI study of porcine lenses also imaged PC, PE, PA using exact mass measurements.103 
Deeley et al. utilised MALDI-MSI to identify changes in the distribution of sphingolipids such as Cer and 
DHSM in the human lens with age (as shown previously in Figure 1.11).12 Nevertheless, the analysis was 
only performed in positive ion mode and only SM, DHSM, Cer and DHCer were analysed. More recently, 
a MALDI-MSI study on lens ageing provided the first insight into lysosphingomyelin (LSM) and 
DHLacCer distribution in the human lens.118 Moreover, data from this study suggests that lysolipids could 
be an indicator of human lens ageing.118 
Changes in the distribution of SLs with age has been demonstrated using imaging mass spectrometry 
(Figure 1.16).12 With age, it was observed that DHCer increased in relative abundance in the lens nucleus 
while DHSM formed a dense annular distribution in the barrier region of an older lens.12 It was hypothesised 
that the increase in DHCer levels in the lens nucleus was a result of DHSM degradation, as they are 
structurally related. However, quantitative data suggests that DHSM abundance remains unchanged in the 
lens nucleus with age (Figure 1.17A),53 while DHCer levels increase approximately 1000-fold (Figure 
1.17B). The mechanism that leads to the increase in Cer and DHCer with age is currently unknown. As 
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there is no enzymatic activity in the nucleus in order to synthesise these molecules,42, 43 it has been 
postulated that the breakdown of other sphingolipid classes may contribute to the formation of Cer and 
DHCer observed with age. Furthermore, although the abundance of DHSM remains unchanged in the lens 
nucleus with age, quantitative data has shown that there is an increase in DHSM in the barrier region, which 
is consistent with results obtained from lens imaging (Figure 1.16).12   
 
 
Figure 1.16: The changes in distribution for SM (d18:0/16:0) and Cer (d18:0/16:0) in a 23-, 64- and 70-
year old lenses generated by imaging mass spectrometry.12 
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Figure 1.17: Total (A) DHSM and (B) DHCer present in individual human lens nuclei of different ages.53 
It is observed that DHSM level is constant from lenses of young to old ages. In contrast, the abundance of 
DHCer increases about a thousand-fold in the older lenses compared to the young ones. The solid line is a 
generalised additive model fit; the dashed lines provide a 95% confidence band. 
 
Together, these MSI studies have given greater insight into the lipid changes that occur with age. However, 
the spatial distribution of many lens sphingolipids, e.g., DHSM3 and DHST and complex GSL such as 
gangliosides are yet to be determined. A more thorough imaging study containing the spatial distribution 
of these lipids is essential to understand the lens composition in different regions of the lens. 
1.6 Summary 
Although some of these glycosphingolipids have been identified and quantified in the lens, most studies 
have used whole lens extracts for identification and quantification. The lack of spatial distribution and also 
their abundance in each region of the lens are missing pieces of information, which are essential to elucidate 
the whole sphingolipidome of the lens. The mechanisms underlying the sudden increase in DHCer in the 
lens nucleus after the age of 40 remain unanswered. 
1.7 Aims 
Therefore, the aims of this PhD project were to determine: 
• the distribution of each SL and GP class in the human lens, 
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• changes to these distributions with age, 
• the quantitative alterations to lens lipids in the nucleus, cortex and barrier with age, 
• if complex glycosphingolipid degradation in the nucleus is the source of DHCer accumulation 
with age. 
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Chapter 2: Method Development 
2.1 Methods development for MALDI-Imaging 
2.1.1 Background 
MALDI requires the deposition of a layer of matrix, which can be any compound that can absorb the 
laser wavelength to allow gentle energy transfer to ionise the analytes on the tissue. The MALDI process 
is complex, where the matrix aids both desorption and ionisation of the molecules. The matrix plays a 
vital role in diluting and isolating analytes as well as acting as a mediator for energy absorption.1 Further 
information about multiple models of ionisation such as photoionisation and photochemical reaction 
pathways have been reviewed previously in literature.1 The laser then rasters across the tissue and the 
mass spectra at a defined X,Y-coordinate is translated into pixels forming an image based on ion 
intensity. The spatial resolution of an image is dependent on the laser beam size, the distance between 
each laser spot and the matrix crystal size. A modified schematic diagram of the MALDI work flow for 
human lens is shown in Figure 2.1. 
 
 
Figure 2.1: A modified schematic diagram of MALDI imaging workflow for human lens analysis. A) 
sample preparation; B) MS analysis; and C) data processing.2 
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Matrix deposition is an essential step during the sample preparation process to ensure molecules are 
extracted and desorbed efficiently and uniformly across the tissue surface.3, 4 In wet extraction 
approaches, the matrix should be deposited on the tissue surface to produce a uniform layer of crystals 
that dissolves the analytes and facilitates the desorption or ionisation process during laser irradiation.5 
Furthermore, deposition of the matrix solution should not dissolve the analytes excessively to maintain 
their spatial distribution in the tissue.6 This can be achieved by repeated steps of applying a minimal 
amount of matrix deposition and then drying.  
Methods for matrix application have been developed to maximize ion generation and increase the spatial 
resolution of an image.4, 7 These include dried droplet deposition, electrospray deposition, inkjet 
deposition and airbrush deposition.6, 8 Manual aerosol spray deposition provides good homogeneity and 
spatial resolution of the images nevertheless, this is a manual procedure and suffers from low 
reproducibility.9, 10 If the tissue is too wet during the process, large matrix crystals will be formed, 
resulting in the loss of spatial resolution. Alternatively, if it is too dry the matrix molecule will not be 
incorporated into the tissue effectively. Therefore, automated matrix deposition systems such as 
ImagePrep™ (Bruker Daltonics Inc.), TM Sprayer™ (HTX Technologies, LLC) and Potrait Spotter™ 
(Labcyte Inc.) have been developed.4, 10, 11 The advantage of automated system is the reduction in 
sample-to-sample variation in matrix deposition, which leads to irreproducible mass spectral images. 
However, wet deposition strategies can lead to delocalisation of analytes via diffusion through 
droplets.12 An alternative strategy for matrix deposition is sublimation, which will be discussed in 
Section 2.1.5 
The aim of this chapter is to trial matrix deposition methods suitable for lens lipid imaging and optimise 
matrix choice for lens lipid detection. 
2.1.2 Tissue preparation 
Sample preparation is the key to obtaining high quality MALDI MS images. Essential factors during 
the preparation of a lens tissue slice include the slicing temperature, thickness of the slice, and the 
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consistency of the tissue and matrix deposition. The packed fibre cells in the lens are especially 
susceptible to damage during cutting. Careless handling may result in undesirable loss of tissue, and 
hence loss of chemical and spatial information.5 To prevent this, different mounting techniques were 
tested. Previous studies on lens proteins have shown that a methanol13, 14 or ethanol soft-landing 
technique15 can aid in maintaining the integrity of the lens tissue. This technique is not suitable for lipids 
as they are more soluble in ethanol than proteins, which results in lipid delocalisation and compromised 
spatial resolution. In this study, tissues were thaw-mounted onto a cold glass slide using body 
temperature with a finger pressed on the underneath surface of the glass slide. 
For MALDI-MS analysis, lenses were mounted onto a cryostat holder using a minimal amount of OCT 
at – 20 °C in a cryo-microtome (Leica CM 1950, Leica Biosystems, Australia). The lenses were sliced 
in the transverse plane to produce 20 µm thick slices and were thaw-mounted onto the glass slide. The 
samples were immediately stored at -20 °C until analysed. Prior to analysis, samples were dried in a 
desiccator for 10 minutes. 
2.1.3 Mass spectrometry parameters 
The samples were then analysed by an LTQ-Orbitrap XL mass spectrometer (ThermoScientific, 
Australia) equipped with a MALDI source. The entire surface of the human lens was examined with a 
raster step size of 100 µm. The laser performed 50 shots per spot with a summed spectrum collected 
from each spot. The mass resolution at m/z 400 was 33000 and the mass range acquired was m/z 400-
2000. The instrument was externally calibrated using commercially available Calmix for LTQ-Orbitrap 
(Sigma Aldrich, Australia) in both ion modes. MS imaging data were visualized by ImageQuest 1.0 
(ThermoScientific, Australia). 
2.1.4 ImagePrep™ 
The automated matrix deposition system used in the current study was an ImagePrep™ system (Bruker 
Daltonics, Bremen) as shown in Figure 2.2.16 
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Figure 2.2: The ImagePrep™ station for matrix deposition. (Image from ImagePrep Manual)16 
 
Figure 2.3: (A) The set-up of the sample prior to matrix deposition. (B) A schematic diagram of the 
spray head. 
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The ImagePrep™ device produces matrix aerosol by vibrational vaporisation.  The set-up of the spray 
chamber is shown in  
Figure 2.3A. The matrix solution was first loaded into the matrix reservoir and upon the vibration of 
the thin spray sheet, a mist of matrix solution was produced through the pinholes as shown in  
Figure 2.3B. During the entire preparation process the spray chamber was filled with nitrogen to prevent 
sample oxidation and to obtain reproducible experimental conditions independent of the ambient 
humidity. The sample was placed on top of the optical sensor, without blocking its activity. The optical 
sensor monitors light scattered from the crystalline matrix layer to control relevant parameters such as 
wetness, matrix layer thickness, drying rate, deposition periods and intervals. It takes 30-100 cycles to 
apply a homogenous coating of matrix to a typical microscope glass slide, depending on the desired 
matrix thickness. Each cycle consists of three phases: i) deposition of the droplet layer; ii) incubation, 
which is the waiting period after each spray (no active drying with gas flow); and iii) active drying 
(partially/completely). Increased incubation time provides better incorporation of analytes into the 
matrix crystals, however it also increases the overall preparation time. The wetness of the tissue relies 
on the drying phase. Although a wetter tissue allows a better extraction, the spatial resolution can be 
sacrificed due to analyte delocalisation. These parameters can be optimised manually depending on 
individual sample needs. 
Table 2.1: Instrument parameters for ImagePrep™. 
Spray time Incubation time Drying time Total cycles 
2 s 30 s 60 s 200 
 
Table 2.1 shows the most optimum parameters used in this experiment. A total of 200 spray cycles were 
applied onto a lens tissue on a glass slide with 20 mg/ml 2,5-dihydroxybenzoic acid (DHB) in 50% 
methanol + 0.2% trifluoroacetic acid (TFA) as the matrix solvent. The deposition time for the entire 
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process was approximately 90 minutes.  
A snapshot of matrix post-deposition is shown in Figure 2.4A. Despite being a commonly used matrix 
for MALDI-MS analysis, DHB forms long and visible crystals on the tissue using this matrix deposition 
method, which is not suitable for imaging. This agrees with previous findings, where DHB crystals 
appear to be longer than other matrices and the formation of the crystals is highly dependent on the 
solvent evaporation rate.17 These crystals are larger than the laser beam diameter (~60 μm), as shown 
in Figure 2.4B, and therefore affect the spatial resolution of the image acquired.  
 
Figure 2.4: A) Snapshot of DHB crystals formed on tissue via the camera in the MALDI source. B) 
Snapshot of laser rastering across the tissue during MS analysis at 100 μm spatial resolution. Ablation 
spots are circled in red. 
  
A) B) 
500μm 500μm 
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Figure 2.5: A) An optical image of a 74 year-old human lens tissue after DHB matrix deposition by 
ImagePrep™. The white spots in the red circle showed excessive matrix (not homogenous) deposited 
on the tissue. B) A total ion count diagram of the same lens tissue. The “hot spot” is shown towards the 
left of the image (red circle) where yellow and red dots are visible. 
Moreover, the crystals formed on the tissue were not homogeneous, where larger crystals tended to 
form around the edges of the tissue (red circled region in Figure 2.5A). This created what is referred to 
as matrix “hot spots”. Figure 2.5B shows that a higher total ion count is observed at the regions with an 
increased matrix crystal density while the areas with lesser matrix have a relatively lower total ion 
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count. The use of solvent also encourages analyte delocalisation, as some lipid ions were detected 
outside the tissue area as demonstrated in Figure 2.5B. 
 
Figure 2.6: A) The distribution image of m/z 743 which corresponds to the [M+K]+ ion of SM 
(d18:0/16:0); and B) The distribution image of m/z 578 which corresponds to the [M+K]+ ion of Cer 
(d18:0/16:0). 
The distribution image of individual lipids in the lens is also affected by these “hot spots”. The 
distribution images for SM (d18:0/16:0) (Figure 2.6A) and Cer (d18:0/16:0), (Figure 2.6B) were 
obtained from the same lens slice shown in Figure 2.5. As with the total ion count, these images clearly 
demonstrate that the lipid ions are more abundant at “hot spots” than other areas where less matrix 
crystals were observed. The influence of the matrix “hot spots” cannot be neglected as they mask the 
real distribution and relative abundance of the lipid investigated and decrease the spatial resolution of 
the image. The higher abundance of the ion at the “hot spots” may be explained by better incorporation 
of analytes into the matrix crystals.18 It is possible that the matrix solvent sat on the surface for a longer 
period to form larger crystals compared to other areas.  
Several attempts to improve the Imageprep™ deposition method were performed, however, these were 
not successful. As this wet method requires the matrix to be in an organic solvent that is compatible 
with Imageprep™, other matrices with a lower solubility in methanol or acetonitrile could not be 
investigated. This method is not suitable for lens lipid analysis as it requires matrices that are soluble 
in a limited range of organic solvents, produces large crystals, and does not form a homogeneous layer 
of matrix and results in poor spatial resolution. 
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2.1.5 Sublimation 
The dry methods used previously for imaging include “dusting” the dry matrix onto the tissue and 
sublimation, with the latter forming a more homogeneous layer of matrix.19, 20 These solvent-free 
systems often form a finer layer of matrix crystals on the tissue where sensitivity and spatial resolution 
can be enhanced, however, the extraction of analytes may not be as efficient as a matrix solvent system.  
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Figure 2.7: (A) The set up of a sublimation apparatus for MALDI-MS analysis sample preparation. (B) 
Schematic diagram of matrix sublimation process. 
The set up of a sublimation apparatus for matrix deposition and a schematic diagram of the sublimation 
process is shown in Figure 2.7A and B, respectively. Pre-weighted glass slides with the adhered sample 
are fixed upside-down on a metal plate at the bottom of the inner flat surface of the glass condenser 
using a heat conductive tape. Matrix (100 mg) was added to the bottom section of the apparatus, 
dissolved with a small amount of acetone and then dried by rotating a constant nitrogen flow slowly 
(A) 
(B) 
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around the rim of the sublimator. This helped to achieve a more homogeneous layer of matrix. The two 
sections of the sublimator were assembled with an O-ring seal and were connected to a vacuum pump 
to produce a chamber pressure of –16 psi. The condenser was then filled with ice and water.  
The sublimator was placed in a sand bath and the amount of matrix condensed onto the tissue was 
empirically determined by adjusting the temperature of the sand bath (heat applied to matrix) and time 
of sublimation. These were optimised based on the matrix used as the heat applied was approximately 
50 oC lower than its boiling point. A matrix layer that was too thin yielded very few ions and a matrix 
layer that was too thick yielded only matrix ions. After this time, the post-deposition glass slide with 
sample was weighed again to calculate the amount of matrix deposited. The optimised conditions, 
shown in Table 2.2 yield approximately 3 mg (~ 0.16 mg/cm2) of matrix deposited on the glass slide. 
The time was optimised for each matrix to achieve the same amount of deposition on the sample. 
Table 2.2: Sublimation conditions for different matrices. 
Matrix Temperature (°C) Time (min) 
2,5-dihydrobenzoic acid (DHB) 110 10 
1,5-diaminonapthalene (DAN) 120 6 
2-mercaptobenzothiazole (MBT) 115 8 
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Figure 2.8: A) Glass slide with samples before (left) and after sublimation of DHB (right). B) Snapshot 
of laser rastering across the sublimed tissue during MS analysis at 100 μm spatial resolution.  
A layer of homogeneous fine matrix crystals were deposited onto the glass slide after sublimation as 
shown Figure 2.8A. A magnified snapshot of the laser rastering across the sublimed tissue showed that 
no large crystals were formed Figure 2.8B. The crystals formed are visible as a layer of powder and are 
smaller than the laser beam. This is in contrast with the large crystals formed during wet matrix 
deposition (see Figure 2.4B) and suggests that the dry method avoids the formation of large crystals on 
human lens tissue and hence enables a higher spatial resolution for imaging. 
500μm 
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Figure 2.9: A) Optical image of a 51 year-old human lens. B) Total ion count image for the same human 
lens. C) The distribution image of m/z 705 which corresponds to the [M+H]+ ion of SM (d18:0/16:0); 
and D) The distribution image of m/z 540 which corresponds to the [M+H]+ ion of Cer (d18:0/16:0). 
Figure 2.9A-D shows the optical image, total ion count, distribution of SM (d18:0/16:0) and Cer 
(d18:0/16:0) of a 51 year-old human lens tissue slice, respectively. The tissue was sliced with the iris 
attached during the freezing process, which is represented by the green area around the edge of the lens 
(anterior to the anterior lens surface) in Figure 2.9B. The total ion distribution of the lipid in the lens is 
homogeneous across the lens. In Figure 2.9C and D, the images of sphingomyelin and ceramide 
distribution are of greater spatial resolution and there are minimal matrix “hot spots” compared to the 
images acquired by a wet deposition method (cf. Figure 2.6).  
Matrices were chosen according to the maximum number of lipid classes detected during MSI, as shown 
in Table 2.3. There were the least number of lipid classes detected with DHB in both modes. DAN 
detected the most classes of lipids in negative ion mode such as PA, PS, PE, LPE, CerP, DHCerP, ST, 
DHST, SM3, DHSM3, DHGM1, DHGM3 and DHSialyl-LeX. In positive ion mode, 5 lipid classes were 
detected by MBT which were SM, DHSM, Cer, DHCer and DHLacCer. Therefore, MBT was used for 
positive ion mode and DAN was used for negative ion mode during MSI. 
Anterior 
Anterior Anterior 
Anterior 
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Table 2.3: Number of lipid classes detected in positive and negative ion mode for each matrix. 
Matrix 
No. of lipid class detected 
 in positive mode 
No. of lipid class detected 
in negative mode 
2,5-dihydrobenzoic acid (DHB) 4 2 
1,5-diaminonapthalene (DAN) 2 13 
2-mercaptobenzothiazole (MBT) 5 2 
 
2.1.6 Mass spectrometry parameters for MSI 
The samples were analysed by an LTQ-Orbitrap XL mass spectrometer (ThermoScientific, Australia) 
equipped with a MALDI source. The entire surface of the human lens was examined with a raster step 
size of 100 µm. The laser performed 50 shots per spot with a summed spectrum collected from each 
spot. Mass spectra were acquired in both positive (using MBT as the matrix) and negative ion mode 
(using DAN as the matrix). The mass resolution at m/z 400 was 33000 and the mass range acquired was 
m/z 400-2000. The instrument was externally calibrated using commercially available Calmix for LTQ-
Orbitrap (Sigma Aldrich, Australia) in both ion modes. MS imaging data were visualized by 
ImageQuest 1.0 (ThermoScientific, Australia). SM, DHSM, LacCer, Cer and DHCer were detected on 
lens slices in positive ion mode, with MBT as the matrix. Other classes of sphingolipids were detected 
in negative ion mode on adjacent lens slices using DAN. The extracted ion count of each sphingolipid 
was normalized to the total ion count of the spectra to obtain the abundance of the ions. Therefore, the 
abundance was compared within the same ion mode and same lens only. 
2.1.7 Summary 
In conclusion, sublimation requires a shorter preparation time (~15 mins) as compared to the 
ImagePrep™ method (~90 mins) and produces a more homogeneous layer of crystals. Although this is 
a manual process, which may not produce an identical coating of matrix each time, parameters such as 
temperature and time are monitored with each sample preparation to minimise inconsistency. Therefore, 
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samples need to be weighed before and after sublimation to ensure the same possible amount of matrix 
(~3 mg) is coated each time.  
2.2 Method Development for Lipid Quantification (Chapter 5) 
2.2.1 Lens Dissection 
Sixteen lenses between the ages of 8 and 74 were dissected as described previously.21 Trephines with 
diameters of 8, 6, and 4.5 mm were used to dissect lenses into the outer (>8 mm), barrier (8–6 mm), 
inner (6–4.5mm), and core (4.5 mm) regions, respectively (Figure 2.10).  
The trephines were precooled to -20°C. Lenses were decapsulated and placed into a precooled 
polytetrafluoroethylene (Teflon; DuPont, Wilmington, DE) holder with a 9-mm diameter. An 8-mm 
trephine was used to remove the outer tissue. The resultant billet was transferred to an 8-mm 
polytetrafluoroethylene holder, and barrier tissue was removed with a 6-mm trephine. A cold scalpel 
was used to remove approximately 1 mm from each end from the cylinder (inner core), which was 
inserted into a 6-mm holder and refrozen. After refreezing, a 4.5-mm trephine was used to separate the 
core region from the inner region. 
 
Figure 2.10: Illustration of the four regions of the lens obtained by dissection.21 
2.2.2 Lipids quantification 
A representative spreadsheet that was used for quantification is shown in Figure 2.11. The ion 
abundance of each lipid were obtained directly from the spectrum. The isotope distribution was 
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calculated from isotope models for each lipid ion. This was used to predict the ion abundance of the 
first, second, third, fourth and fifth isotopes. The total ion abundance including all the isotopes were 
summed and normalised to the concentration of the internal standard. The amount of each lipid was 
then divided by the weight of lens tissue to give the concentration of lipid per gram of tissue. 
 
Figure 2.11: A representative spreadsheet used for quantification of lipids. 
  
60 
 
2.3 References 
1. Karas, M.;  Glückmann, M.; Schäfer, J., Ionization in matrix-assisted laser 
desorption/ionization: singly charged molecular ions are the lucky survivors. Journal of Mass 
Spectrometry 2000, 35 (1), 1-12. 
2. Buchberger, A. R.;  DeLaney, K.;  Johnson, J.; Li, L., Mass Spectrometry Imaging: A Review 
of Emerging Advancements and Future Insights. Analytical Chemistry 2018, 90 (1), 240-265. 
3. Amstalden van Hove, E. R.;  Smith, D. F.; Heeren, R. M. A., A concise review of mass 
spectrometry imaging. Journal of Chromatography A 2010, 1217 (25), 3946-3954. 
4. Végvári, Á.;  Fehniger, T. E.;  Gustavsson, L.;  Nilsson, A.;  Andrén, P. E.;  Kenne, K.;  
Nilsson, J.;  Laurell, T.; Marko-Varga, G., Essential tactics of tissue preparation and matrix nano-
spotting for successful compound imaging mass spectrometry. Journal of Proteomics 2010, 73 (6), 
1270-1278. 
5. Vidová, V.;  Pól, J.;  Volný, M.;  Novák, P.;  Havlíček, V.;  Wiedmer, S. K.; Holopainen, J. 
M., Visualizing spatial lipid distribution in porcine lens by MALDI imaging high-resolution mass 
spectrometry. Journal of Lipid Research 2010, 51 (8), 2295-2302. 
6. Baluya, D. L.;  Garrett, T. J.; Yost, R. A., Automated MALDI Matrix Deposition Method with 
Inkjet Printing for Imaging Mass Spectrometry. Analytical Chemistry 2007, 79 (17), 6862-6867. 
7. Chaurand, P.;  Norris, J. L.;  Cornett, D. S.;  Mobley, J. A.; Caprioli, R. M., New Developments 
in Profiling and Imaging of Proteins from Tissue Sections by MALDI Mass Spectrometry. Journal of 
Proteome Research 2006, 5 (11), 2889-2900. 
8. Axelsson, J.;  Hoberg, A.-M.;  Waterson, C.;  Myatt, P.;  Shield, G. L.;  Varney, J.;  Haddleton, 
D. M.; Derrick, P. J., Improved Reproducibility and Increased Signal Intensity in Matrix-assisted Laser 
Desorption/Ionization as a Result of Electrospray Sample Preparation. Rapid Communications in Mass 
Spectrometry 1997, 11 (2), 209-213. 
9. Murray, K. K.; Russell, D. H., Aerosol Matrix-Assisted Laser Desorption Ionization Mass 
Spectrometry. Journal of the American Society for Mass Spectrometry 1994, 5 (1), 1-9. 
10. Yamada, Y.;  Hidefumi, K.;  Shion, H.;  Oshikata, M.; Haramaki, Y., Distribution of 
chloroquine in ocular tissue of pigmented rat using matrix-assisted laser desorption/ionization imaging 
quadrupole time-of-flight tandem mass spectrometry. Rapid Communications in Mass Spectrometry 
2011, 25 (11), 1600-1608. 
11. Aichler, M.; Walch, A., MALDI Imaging mass spectrometry: current frontiers and 
perspectives in pathology research and practice. Laboratory Investigation 2015, 95 (4), 422-431. 
12. Dong, Y.;  Li, B.;  Malitsky, S.;  Rogachev, I.;  Aharoni, A.;  Kaftan, F.;  Svatoš, A.; Franceschi, 
P., Sample Preparation for Mass Spectrometry Imaging of Plant Tissues: A Review. Frontiers in Plant 
Science 2016, 7 (60). 
13. Grey, A. C.;  Chaurand, P.;  Caprioli, R. M.; Schey, K. L., MALDI Imaging Mass Spectrometry 
of Integral Membrane Proteins from Ocular Lens and Retinal Tissue†. Journal of Proteome Research 
2009, 8 (7), 3278-3283. 
14. Grey, A. C.; Schey, K. L., Age-Related Changes in the Spatial Distribution of Human Lens α-
Crystallin Products by MALDI Imaging Mass Spectrometry. Investigative ophthalmology & visual 
science 2009, 50 (9), 4319-4329. 
15. Han, J.; Schey, K. L., MALDI Tissue Imaging of Ocular Lens α-Crystallin. Investigative 
Ophthalmology & Visual Science 2006, 47 (7), 2990-2996. 
16. In ImagePrep user manual, Bruker Daltonic: 2010; Vol. Revision 3. 
17. Dai, Y.;  Whittal, R. M.; Li, L., Confocal Fluorescence Microscopic Imaging for Investigating 
the Analyte Distribution in MALDI Matrices. Analytical Chemistry 1996, 68 (15), 2494-2500. 
61 
 
18. Le, C. H.;  Han, J.; Borchers, C. H., Dithranol as a MALDI Matrix for Tissue Imaging of 
Lipids by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. Analytical Chemistry 2012, 
84 (19), 8391-8398. 
19. Puolitaival, S. M.;  Burnum, K. E.;  Cornett, D. S.; Caprioli, R. M., Solvent-Free Matrix Dry-
Coating for MALDI Imaging of Phospholipids. Journal of the American Society for Mass Spectrometry 
2008, 19 (6), 882-886. 
20. Hankin, J. A.;  Barkley, R. M.; Murphy, R. C., Sublimation as a method of matrix application 
for mass spectrometric imaging. Journal of the American Society for Mass Spectrometry 2007, 18 (9), 
1646-1652. 
21. Friedrich, M. G.; Truscott, R. J. W., Large-Scale Binding of α-Crystallin to Cell Membranes 
of Aged Normal Human Lenses: A Phenomenon That Can Be Induced by Mild Thermal Stress. 
Investigative Ophthalmology & Visual Science 2010, 51 (10), 5145-5152. 
62 
 
Chapter 3: Distribution of Sphingolipids in the Human Lens by 
Mass Spectrometry Imaging 
Jo Ann Seng a, Jessica R. Nealon b,d, Stephen J. Blanksbyc, Todd W. Mitchell b,d* 
 
a School of Chemistry, Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522, 
Australia. 
b School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, NSW 2522, 
Australia. 
c Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD 
4000, Australia. 
d Illawarra Health and Medical Institute, University of Wollongong, NSW 2522, Australia. 
* Correspondence to: T.W. Mitchell, School of Medicine, University of Wollongong, NSW 2522, Australia. 
Email: toddm@uow.edu.au 
 
  
 
  
63 
 
Abstract 
The human lens sphingolipdome is unique in that the most abundant sphingolipids contain a saturated 
dihydrosphinganine backbone. Following recent data that elucidated and characterised the lens 
sphingolipidome, we aimed to explore the spatial distribution of these sphingolipids in the human lens. 
Sections of two human lenses aged 51 and 67 were analysed by matrix-assisted laser desorption ionisation 
imaging mass spectrometry. This study reveals the localisation of sphingolipids in different regions of the 
lens. This is the first study to determine the distribution of sulfatides, lactosylceramide sulfates and complex 
gangliosides in the adult human lens, which may be significant for future studies examining age-related 
changes to the lipid distribution of the human lens. 
Keywords 
gangliosides, glycosphingolipids, human lens, mass spectrometry imaging, lactosylceramide sulfate, 
lipidomics, sialyl Lewis acid, sulfatides 
Highlights 
• Human lens sphingolipid distribution was mapped using MALDI-MS 
• First distributions of gangliosides, sulfatides, lactosylceramide sulfates were studied. 
• Lipids such as ceramides and ceramide phosphates have complementary distributions. 
Abbreviations 
2,5-diaminonapthalene (DAN), 2-mercaptobenzathiazole (MBT), ceramide (Cer), ceramide phosphate 
(CerP), desorption electrospray ionisation (DESI), dihydroceramide (DHCER), dihydroceramidephosphate 
(DHCerP), dihydromonosialotetrahexosylganglioside (DHGM1), dihydromonosialodihexosylganglioside 
(DHGM3), dihydrolactosylceramide (DHLacCer), dihydrolactosylceramide sulfate (DHSM3), 
dihydrosialyl Lewis acid (DHSialyl-LeX), dihydrosphingomyelin (DHSM), dihydrosulfatide (DHST), 
lactosylceramide (LacCer), lactosylceramide sulfate (SM3), lysophosphatidylethanolamine (LPE), 
64 
 
lysosphingomyelin (LSM), matrix-assisted laser desorption ionisation (MALDI), mass spectrometry 
imaging (MSI), optimal cutting temperature (OCT), phosphatidylethanolamine (PE), phosphatidylserine 
(PS), sphinganine (d18:0), sphingolipid (SL), sphingomyelin (SM), sphingosine (d18:1), sulfatide (ST) 
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3.1 Introduction 
The human lens is comprised of fibre cell layers, with the central layers formed in utero or shortly after 
birth (the nucleus) and concentric layers added throughout the human lifespan (the cortex).1-4 The lens fibre 
cells lose their organelles and nuclei after differentiating to maintain lens transparency.1, 3, 5 The nucleus can 
be divided into two sub regions; the core and the inner region. The core is formed in utero and the inner 
region is formed around the core immediately after birth.6, 7 The cortex can be separated into two sub 
regions; the barrier and the outer cortex. At middle age (approximately 40-50 years), the barrier region is 
formed outside the inner region, which is thought to be the result of age-related modifications to proteins in 
the metabolically inactive nuclear region.8, 9 Finally, the outer cortex is comprised of newly formed fibre 
cells that are still metabolically active.10 Owing to its unique growth pattern, there is no membrane protein 
or lipid turnover in the lens nucleus.11, 12 As a result of the lack of turnover, there are significant alterations 
to both protein structure and lipid composition that occur with age2, 12-17.  
The lipid profile of the human lens is different from other tissues in the human body or other animals.13 In 
the human lens, lipids are mainly comprised of sphingolipid (SL) with a saturated sphinganine (d18:0) 
backbone.2, 13, 18 The most abundant sphingolipid present in the lens is dihydrosphingomyelin (DHSM), 
which contributes approximately 72% of total sphingolipid and approximately 47% of total phospholipid.13 
This is in contrast to other animal lenses where DHSM is approximately 3% of total phospholipids.1 
To better study lens pathologies that are associated with biochemical alterations to lens constituents, 
knowledge of the spatial distribution of lens lipids is essential in order to understand the difference in lipid 
profile in older (nuclear) and younger (cortical) fibre cells. Mass spectrometry imaging (MSI) has emerged 
as a complementary tool to study the distribution of specific lipids in tissue.19-22 Matrix-assisted laser 
desorption ionization (MALDI) mass spectrometry has been a key technique in the success of MSI.23 
MALDI requires the deposition of a layer of matrix, which can be any compound that can absorb the laser 
wavelength to allow gentle energy transfer to ionise the analytes in the tissue and also aid desorption of 
analytes.19, 22 
66 
 
Previous MSI of human, bovine and porcine lens lipids has been performed with MALDI and desorption 
electrospray ionisation (DESI) mass spectrometry.13, 24-28 The direct analysis of the porcine lens using 
MALDI detected only two ceramide phosphates (CerPs) and sphingomyelins (SMs).24 Deeley et al. has also 
identified age-related changes in the distribution of ceramides (Cers), dihydroceramides (DHCers) and 
DHSM in adult human lens.13 More recently, MALDI has also been used to provide the first data describing 
the distribution of lysosphingomyelins (LSMs) and dihydrolactosylceramides (DHLacCers) in the human 
lens.29 The distribution of a wider range of lipids including CerP, phosphatidylethanolamine (PE), 
phosphatidylserine (PS), lysophosphatidylethanolamine (LPE) and cholesterol have been studied in the 
human lens using DESI.25 However, lipids in the lens tissue cannot be desorbed by DESI without the 
presence of a strong acid, which causes a physical disruption to the tissue structure.25 The physical 
disruption of the tissue means that the spatial distribution of lipids by DESI may be compromised. Ellis et 
al. predict that this may be a consequence of the tightly-packed laminae of fibre cells and their relatively 
high protein concentration in comparison with other human tissues.25 Together, these MSI studies provide 
new insight into the distribution of some lipid classes in the lens.  
The recent discovery of other low abundant lipid classes such as dihydrolactosylceramide sulfate (DHSM3), 
dihydrosulfatide (DHST), and other gangliosides,30 and the large alterations in sphingolipid distribution 
with age12 highlights the need for further understanding of sphingolipid distribution in the human lens. The 
aim of this study was to complete the distribution map of sphingolipids in the adult human lens, with a 
particular focus on the sphingolipids that have been recently identified in this unique tissue utilizing 
MALDI-MSI.30 
3.2 Materials and Methods 
3.2.1 Materials 
The matrices 2-mercaptobenzathiazole (MBT) and 2,5-diaminonapthalene (DAN) were purchased from 
Sigma Aldrich (Castle Hill, Australia). Glass microscope slides for tissue mounting were purchased from 
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Proscitech (Townsville, Australia). The optimal cutting temperature (OCT) compound was purchased from 
Sakura Finetek (Torrance, USA). 
3.2.2 Lenses 
Human lenses were obtained from eyes donated to the NSW Lions Eye Bank at the Sydney Eye Hospital, 
(Sydney, Australia) within 2–6 hours of death, and were stored immediately at – 80 °C until required. All 
work was approved by the human research ethics committees at the University of Wollongong (HE 13/401).  
3.2.3 MALDI-MS 
For MALDI-MS analysis, lenses were mounted onto a cryostat holder using a minimal amount of OCT at 
– 20 °C in a cryo-microtome (Leica CM 1950, Leica Biosystems, Australia). The lenses were sliced in the 
transverse plane to produce 20 µm thick slices and were thaw-mounted onto the glass slide. The samples 
were immediately stored at -20 °C until analysed. Prior to analysis, samples were dried in a desiccator for 
10 minutes. Matrices were then applied via sublimation at 30 mTorr and 120 °C for MBT and 112 °C for 
DAN. The samples were removed after 8 minutes and 6 minutes, respectively. 3 mg (~ 0.16 mg/cm2) of 
matrix were applied on each sample. The samples were then analysed by an LTQ-Orbitrap XL mass 
spectrometer (ThermoScientific, Australia) equipped with a MALDI source. The entire surface of the 
human lens was examined with a raster step size of 100 µm. The laser performed 50 shots per spot with a 
summed spectrum collected from each spot. Mass spectra were acquired in both positive (using MBT as the 
matrix) and negative ion mode (using DAN as the matrix). The mass resolution at m/z 400 was 33000 and 
the mass range acquired was m/z 400-2000. The instrument was externally calibrated using commercially 
available Calmix for LTQ-Orbitrap (Sigma Aldrich, Australia) in both ion modes. MS imaging data were 
visualized by ImageQuest 1.0 (ThermoScientific, Australia). SM, DHSM, LacCer, Cer and DHCer were 
detected on lens slices in positive ion mode, with MBT as the matrix. Other classes of sphingolipids were 
detected in negative ion mode on adjacent lens slices using DAN. The list of m/z for each lipid is shown in 
Table S 3.1. The extracted ion count of each sphingolipid was normalized to the total ion count of the spectra 
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to obtain the abundance of the ions. Therefore, the abundance was compared within the same ion mode and 
same lens only. 
3.3 Results and Discussion 
3.3.1 MALDI Imaging of Sphingolipids in Human Lens 
In this study, MALDI-MSI was used to analyse the sphingolipid composition and distribution of two female 
human lens samples from donors that were 51 and 67 years of age at the time of death. There were 51 
sphingolipid species detected in the human lens based on accurate mass measurements (<3 ppm).  
 
Figure 3.1: MALDI-MS image of a transverse section of a 51 year-old human lens highlighting the different 
regions of the lens: core (C), inner (I), barrier (B) and outer (O).  
An image of SM (d18:0/16:0) in a 51 year-old lens is shown in Figure 3.1. In the image, the different regions 
of the lens were labelled by measuring the distance from the lens centre, as described elsewhere.13 The 
nuclear region was divided into the inner and core region. The core is ~ 1 mm from the lens centre while 
the inner region is between 1.25 mm and 1.5 mm from the lens centre. The barrier region is located ~ 1.5 – 
2 mm from the lens centre, as previously stated by Deeley et al.13 The outer region refers to the region 
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beyond 2.5 mm from the lens centre. 
Nine classes of sphingolipids with a sphinganine (d18:0) base were detected in both lenses, DHSM, 
DHLacCer, DHCer, dihydroceramidephosphate (DHCerP), DHSM3, DHST, 
dihydromonosialodihexosylganglioside (DHGM3), dihydromonosialotetrahexosylganglioside (DHGM1) 
and dihydrosialyl Lewis acid (DHSialyl-LeX). In contrast, only five sphingolipid classes with a sphingosine 
(d18:1) base were detected, i.e., SM, Cer, CerP, lactosylceramide sulfate (SM3) and sulfatide (ST). In 
comparison to previous MSI studies which only detected DHSM, DHCer, LSM, DHLacCer and DHCerP, 
this study includes many other classes of sphingolipids in the lens that were identified to-date. A complete 
distribution of all detectable lens sphingolipids is shown in the supplementary figures (see supplementary 
data).  
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Figure 3.2: The distribution of protonated (a) SM (d18:1/16:0) (m/z 703.59), and (b) SM (d18:0/16:0) (m/z 
705.59) in a 51 year-old and a 67 year-old human lens in positive ion mode using MBT as matrix. Mass 
spectra of SM (d18:0/16:0) detected in a 51 year-old human lens in the (c) core region as indicated by the 
black dot; and the (d) barrier region as indicated by the blue dot. Both spectra in (c) and (d) have been 
normalized to base peak m/z 705.59 in (d).  
(a) 
(b) 
(c) 
(d) 
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3.3.2 Sphingomyelin (SM) & Dihydrosphingomyelin (DHSM) 
The distribution of SM (d18:1/16:0) and SM (d18:0/16:0) in a 51-year old and a 67 year-old human lens are 
shown in Figure 3.2a and b, respectively. In both lenses, SM (d18:1/16:0) was present around the cortex 
region, while its presence in the nucleus is negligible (Figure 3.2a). Figure 3.2c and d show the mass spectra 
obtained from the core (black dot) and barrier (blue dot) regions of the lens. The two most abundant fatty 
acyl chains in the lens sphingolipidome are 16:0 and 24:1, which is consistent across all sphingolipid 
subclasses.30, 32 The masses of these fatty acyl chains are 256 Da and 366 Da, respectively, which equates 
to a mass difference of 110 Da. This is an important pattern used by researchers to identify different 
sphingolipid classes in the lens.30 The most dominant species is SM (d18:0/16:0) at m/z 705, m/z 727 and 
m/z 743 representing its protonated, sodiated and potassiated ions respectively (Figure 3.2c and d). SM 
(d18:0/24:1) is present at m/z 815, m/z 837 and m/z 853, which correspond to proton, sodium and potassium 
adducts respectively. The ion intensity of DHSM is increased around the barrier region (blue dot) as shown 
in Figure 3.2b, forming an annular distribution around the nucleus. This agrees with previous MSI studies 
of human lens lipid using the same approach.1 The ion intensity of DHSM is also higher towards the outer 
limits of the barrier region. This phenomenon is similar for both 51 year-old and 67 year-old lenses (Figure 
3.2a & b).  
We have also observed LDHSM, i.e. SM (d18:0/0:0) based on accurate mass as previously reported by Pol 
et al.29 They were expressed almost homogeneously throughout the lens and did not show an opposite 
distribution trend to their parent molecule of DHSM (supplementaryFigure S 3.1) as reported by Pol and 
colleagues.29 We have also not detected any LSM with a sphingosine backbone (d18:1/0:0) in our studies 
as we have used MBT as a matrix, which has been reported to cause more fragmentation and generates 
interfering ions below m/z 500.33 This may explain the observed difference in LSM.  
3.3.3 Ceramide (Cer), Dihydroceramide (DHCer), Ceramide Phosphate (CerP) & Dihydroceramide 
Phosphate (DHCerP) 
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Figure 3.3: The distribution of (a) DHCer, (b) Cer, (c) DHCerP and (d) CerP in a 51 year-old (left) and a 
67 year-old (right) human lens. DHCer and Cer were analysed in positive ion mode using MBT as matrix 
while CerP and DHCerP were analysed in negative ion mode using DAN as matrix. 
Figure 3.3 shows the distribution of the most abundant Cer and CerP in a 51- and 67-year-old lens. Cer 
(d18:0/16:0) was observed at the highest abundance in the nuclear region of the lens as seen in Figure 3.3a. 
This is in agreement with previous findings by Deeley et al and Pol et al.13, 29 Their analogues with a d18:1 
backbone showed similar distribution (Figure 3.3b). CerP has almost complementary distribution to Cer, as 
seen in Figure 3.3c and d. That is, CerP (d18:1/16:0) and CerP (d18:0/16:0) are more abundant in the cortical 
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region of the lens than the nucleus. This may be due to the hydrolysis of CerP to form Cer.9 The same 
distribution pattern has also been reported previously.29 Other lipid species of CerP and DHCerP detected 
were shown in supplementary Figure S3.2. 
3.3.4 Dihydrolactosylceramide (DHLacCer) 
 
Figure 3.4: The distribution of LacCer (d18:0/16:0) in a 51 year-old and a 67 year-old human lens detected 
in positive ion mode using MBT as matrix. 
Previous data suggest that lactosylceramide (LacCer) species in the lens are only present with a d18:0 
backbone.30 In contrast to other sphingolipid subclasses, DHLacCer with a 14:0 fatty amide was not 
observed, in agreement with previous findings.30 DHLacCer has a similar distribution to DHCer. As shown 
in Figure 3.4, the distribution of LacCer (d18:0/16:0) was concentrated in the core and inner regions, with 
a negligible intensity observed in the outer region. LacCer (d18:0/16:0) and LacCer (d18:0/24:1) have an 
inverse relationship in their distribution in the human lens. While LacCer (d18:0/16:0) was primarily 
distributed around the nucleus, its analogue with a 24:1 fatty amide chain was mainly distributed around 
the cortex (supplementaryFigure S 3.3), as previously reported.29 
3.3.5 Sulfatide (ST) & Dihydrosulfatide (DHST) 
There is a distinct distribution of DHST and ST in both lenses, as shown in Figure 3.5a and b. They form a 
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circular distribution around the nucleus, primarily present in the barrier and cortex of the lens. ST have only 
recently been identified in the lens30 and the data presented here are the first showing their distribution. 
However, we were not able to confirm if the double ring distribution is consistent across all lenses as sample 
was limited. Additional MSI of younger lenses showed that regardless of age, ST and DHST showed the 
same pattern of distribution around the lens cortex (Figure S 3.4). Other lipid species of ST and DHST 
detected were shown in supplementary Figure S 3.5. 
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Figure 3.5: The distribution of (a) DHST, (b) ST, (c) DHSM3 and (d) SM3 in a 51 year-old and a 67 year-
old human lens in negative ion mode using DAN as matrix. 
3.3.6 Lactosylceramide Sulfate (SM3) & Dihydrolactosylceramide Sulfate (DHSM3) 
SM3 has a similar chemical structure to ST, with SM3 having two sugar moieties attached to the 
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sphingolipid backbone while ST has only one. Figure 3.5c shows the distribution of SM3 (d18:0/16:0) to 
be relatively homogeneous across the lens in comparison to SM3 (d18:1/16:0) (Figure 5d) which shows a 
higher intensity of the molecule in the cortex than the nucleus. Other lipid species of SM3 and DHSM3 
detected were shown in supplementary Figure S3.4. 
3.3.7 Other Complex Glycosphingolipid (GSL) & Gangliosides 
 
Figure 3.6: The distribution of (a) DHGM3, (b) DHGM1 and (c) DHSialyl-LeX in a 51 year-old and a 67 
year-old human lens in negative ion mode using DAN as matrix. 
The distribution of gangliosides such DHGM3, DHGM1 and DHSialyl-LeX were also observed in this 
study (Figure 3.6a, b and c). However, their analogues with a sphingosine backbone were below the limit 
of detection and thus not imaged. These lipids were identified based on accurate masses and their previous 
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characterization in the human lens.37, 38 Previous data from lens gangliosides and GSLs show that 
dihydrosphingosine (d18:0) is the major base and the primary fatty amide chains are 16:0 and 24:1.37 GM3 
(d18:0/16:0) is distributed around the cortex of both lenses, with negligible presence in the nucleus as shown 
in Figure 3.6a. GM1 (d18:0/16:0) (Figure 3.6b) is present throughout the whole lens of the 51-year old, with 
a higher abundance surrounding the outer edge of the cortex. In the 67 year-old lens, GM1 (d18:0/16:0) is 
only observed in a faint ring around the edge of the lens. Both of the lenses showed a lower abundance of 
the 24:1 analogue (supplementary Figure S 3.6). In contrast to the two gangliosides, Sialyl-LeX (d18:0/16:0) 
is distributed primarily in the nucleus and barrier region (Figure 3.6c). The 51-year old lens showed a 
slightly wider distribution around the nucleus and the barrier compared to the 67 year-old lens. In contrast 
to the 16:0 analogue, the distribution of Sialyl-LeX (d18:0/24:1) in the 51 year-old lens is around the outer 
edge of the cortex (supplementary Figure S 3.6). This is only the case for the 51 year-old lens as the 
distribution of Sialyl-LeX (d18:0/16:0) and Sialyl-LeX (d18:0/24:1) are similar in the 67 year-old lens 
(Figure 3.6c). 
GSLs are localised on the membrane surface of lens epithelial cells and may play an important role in 
epithelial differentiation and maturation.39, 40 GSLs containing sialic acid, known as gangliosides, are 
involved in cell proliferation, cell-cell interaction, differentiation, oncogenic transformation and signal 
transduction.41-43 Previous studies have shown that GSLs and gangliosides are higher in concentration in 
cataractous and ageing lenses in comparison to normal lenses.44, 45 Ogiso et al. revealed that the ganglioside 
content in the cortical region is higher than the nuclear region in cataractous lenses.46 Our results also 
showed that although these complex GSLs are distributed throughout the lens, GM3 and GM1 have a higher 
abundance around the outer cortex. It has been shown that gangliosides accumulate in association with 
ageing and cataract.46 However, the reason and mechanism behind this increase remain unknown. It has 
been reported that Sialyl-LeX are expressed in cortical cells that are closer to the nuclear fibre cells, which 
agrees with our findings.45 Sialyl-LeX are thought to be involved in differentiation from epithelial cells to 
fibre cells in mammalian lenses.40, 45  
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3.4 Conclusion 
In the current study, we have used MALDI-MS to map the spatial distribution of recently identified 
sphingolipids in the adult human lens, including some complex GSL and gangliosides which have not been 
studied in detail in the last two decades. GSL such as DHST and ST showed a consistent distribution outside 
the nucleus regardless of age, which may suggest that DHST and ST are not required in the metabolically 
inactive nucleus. The functions of these lipids in the lens remain unknown, and whether they are present in 
the same region throughout a human’s lifespan remains to be determined. Mapping of these lipids can now 
be extended to examine age-related changes in lipid distribution across the human lifespan. This brings us 
one step closer to the complete elucidation of the lens sphingolipidome and resolving the distribution of 
each sphingolipid, which is essential to understanding the role of lipids in the development of lens diseases 
such as age-related nuclear cataract and presbyopia. 
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3.5 Supplementary 
Table S 3.1: List of sphingolipid species detected in the human lens by MSI. All the lipids were identified by [M+H]+ 
or [M-H]-. 
Sphingolipids 
  FA m/z [M+H]+ 
Sphingomyelin    
DHSM(d18:0) 14:0  677.560 
  15:0 691.575 
  16:0 705.591 
  17:0 719.607 
  18:0 733.622 
  22:0 789.685 
  24:1 815.701 
SM(d18:1) 14:0 675.544 
  15:0 689.560 
  16:1 701.560 
  16:0 703.575 
  18:0 731.607 
  22:1 785.654 
  22:0 787.669 
  23:0 801.685 
  24:2 811.669 
  24:1 813.685 
Ceramide    
DHCer(d18:0) 14:0 512.504 
  16:0 540.536 
  22:1 622.614 
  22:0 624.629 
  24:1 650.645 
Cer(d18:1) 14:0 510.489 
  16:0 538.520 
  22:1 620.598 
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  22:0 622.614 
  24:1 648.629 
Lactosylceramide    
DHLacCer(d18:0) 16:0 864.641 
  22:0 948.735 
  24:1 974.751 
  24:0 976.766 
  m/z [M-H]- 
Ceramide Phosphate    
DHCerP(d18:0) 16:0 618.486 
  24:1 728.596 
CerP(d18:1) 16:0 616.471 
  24:1 726.580 
Sulfatide    
DHST(d18:0) 14:0 752.498 
  16:0 780.530 
  24:1 890.639 
ST(d18:1) 14:0 750.483 
  16:0 778.514 
  24:1 888.623 
Lactosylceramide Sulfate    
DHSM3(d18:0) 14:0 914.551 
  16:0 942.582 
  24:1 1052.692 
SM3(d18:1) 16:0 940.567 
  22:0 1024.661 
  24:1 1050.676 
DHGM3    
DHGM3(d18:0) 16:0 1153.721 
  24:1 1263.831 
DHGM1    
DHGM1(d18:0) 16:0 1518.853 
  24:1 1628.963 
DHSialyl-LeX    
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DHSialyl-LeX(d18:0) 16:0 1664.911 
  24:1 1775.021 
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Figure S 3.1: MALDI-MS images for SM and DHSM.  
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Figure S 3.2: MALDI-MS images for Cer, DHCer, CerP and DHCerP.  
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Figure S 3.3:MALDI-MS images for DHLacCer. 
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Figure S 3.4: The distribution of DHST 16:0 for 17 year-old and 25 year-old lenses. 
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Figure S 3.5:MALDI-MS images for ST, DHST, SM3 & DHSM 
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Figure S 3.6:MALDI-MS images for DHGM3, DHGM1 & DHSialyl-LeX. 
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Abstract 
The concentration of glycerophospholipids in an adult human lens is remarkably lower than in other animal 
lenses. This is the result of oxidation and other deleterious events that occur over the extended human 
lifespan. The age of fibre cells differs across the lens, ranging from those formed before birth in the core of 
the lens to those formed just prior to death in the outer cortex. Therefore, the distribution of 
glycerophospholipids in the adult human lens should reflect this range however, limited data currently exists 
to confirm this hypothesis. Accordingly, this study aimed to determine the distribution of 
glycerophospholipids in adult human lens using mass spectrometry imaging. To achieve this 20 µm thick 
slices of two human lenses, aged 51 and 67 were analysed by matrix-assisted laser desorption ionisation 
imaging mass spectrometry. The data clearly indicate that intact glycerophospholipids such as 
phosphatidylethanolamine, phosphatidylserine and phosphatidic acid are mainly present in the outer cortex 
region, i.e. the youngest fibre cells, while lyso phosphatidylethanolamine, likely produced by the 
degradation of phosphatidylethanolamine is present in the nucleus (older fibre cells). This study adds further 
evidence to the relationship between fibre cell age and glycerophospholipid composition.  
Keywords 
glycerophospholipids, human lens, imaging mass spectrometry, lipidomics, phosphatidic acid, 
phosphatidylserine 
Abbreviations 
2,5-diaminonapthalene (DAN), desorption electrospray ionisation mass spectrometry (DESI-MS), 
glycerophospholipids (GPs), lysophosphatidylethanolamine (LPE), matrix-assisted laser desorption 
ionisation mass spectrometry (MALDI-MS), optimal cutting temperature (OCT), phosphatidic acid (PA), 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), 
phosphatidylinositol (PI), phosphatidylserine (PS), total ion current (TIC).  
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4.1 Introduction 
The lens is an ocular tissue which grows throughout a species’ life span with newly differentiated fibre cells 
laid down upon older ones that are present from birth.1 There is no protein2 or lipid3 turnover in the lens, 
thus structural and enzymatic proteins and lipids that are present at birth remain for the lifetime of the 
individual. In addition, upon fibre cell differentiation, all intracellular organelles are degraded.4 Therefore, 
lens which is present from birth (known as the nucleus) is mainly composed of membranes packed with 
lipids and proteins.5 Human cellular membranes are comprised of a lipid bilayer containing phospholipids 
and integral membrane proteins. A typical membrane consists mainly of phospholipids and glycolipids of 
different classes, headgroups and fatty acyl chains. Membrane fluidity is partly regulated by the degree of 
unsaturation of the fatty acyl chain.5 Unlike a typical membrane, the human lens membrane is one of the 
most saturated and ordered membranes due to its unique lipid composition.6 It contains a high level of 
cholesterol and saturated sphingolipids such as dihydrosphingolipid.7 Also present in lens membranes are 
glycerophospholipids (GP), which consist of a 3-carbon glycerol backbone where two fatty acids attach at 
the sn-1 and sn-2 positions and a phosphate headgroup attached at the sn-3 position.7 There are six main 
classes of GPs present in the human lens: phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA).8, 
9  
Phosphatidylcholine is the most abundant phospholipid in animals lenses, accounting for 31-46% of total 
phospholipids in rat, chicken, sheep, cow, and pig.7 In contrast, PC in the human lens only accounts for 
11% of the total phospholipidome.7 The most abundant GP in the human lens is phosphatidylethanolamine 
(15%).7, 10, 11 In the human lens, two thirds of phosphatidylethanolamine and phosphatidylserine are 1-O-
alkyl ether-linked, contributing more than 50% and 65% of the total PE and PS content respectively in the 
human lens.7, 10 They differ from the 1-O-alkenyl lipids only by the absence of a cis double bond at the 1-
position.11 These ether-linked phospholipids are believed to be associated with lens transparency, as the 
inhibition of their synthesis causes cataract in mice.12 The general structures of diacyl, 1-O-alkenyl ether 
and 1-O-alkyl ether GPs are shown in Figure 4.1a, b and c respectively. A phospholipid with a PE head 
group, an alkenyl ether-linked, 16-carbon saturated radyl at the sn-1 position and a monounsaturated, 18-
carbon radyl ester-linked at the sn-2 position will be named PE (16:0p/18:1). Alternatively, if R1 is 
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substituted by an alkyl ether-linked 16-carbon long saturated radyl, it will be named PE (16:0e/18:1). Lyso-
derivatives of GPs are also observed, which possess the sn-1 fatty acyl chain only.8, 10  
 
Figure 4.1: The general structures of (a) diacyl GP; (b) 1-O-alkenyl ether; (c) 1-O-alkyl ether. HG, 
headgroup. R1, acyl chain at the sn-1 position; R2, acyl chain at the sn-2 position; sn, stereospecific 
numbering. 
GPs in the human lens have been previously identified and quantified,7, 11, 13-16 however there is limited data 
on the distribution of GPs in the human lens. Ellis and colleagues imaged the human lens using desorption 
electrospray ionisation mass spectrometry (DESI-MS) and showed the distribution of three GPs, namely 
PE (18:1e/18:1), LPE (18:1e) and PS (18:1e/18:1).17 The study did not include other classes of GPs such as 
PA that have been recently identified.8, 9 In this study, we aimed to investigate the distribution of GPs in 
the human lens by using matrix-assisted laser desorption ionisation mass spectrometry (MALDI-MS) which 
provides better spatial resolution compared to DESI-MS.  
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4.2 Materials and Methods 
4.2.1 Materials 
The matrix 2,5-diaminonapthalene (DAN) was purchased from Sigma Aldrich (Castle Hill, Australia). 
Glass microscope slides for tissue mounting were purchased from Proscitech (Townsville, Australia). The 
optimal cutting temperature (OCT) compound used to adhere the lenses to the glass slides was purchased 
from Sakura Finetek (Torrance, USA). 
4.2.2 Lenses 
Human lenses were obtained from eyes donated to the NSW Lions Eye Bank at the Sydney Eye Hospital, 
(Sydney, Australia) within 2–6 hours of death, and were stored immediately at -80 °C until required. All 
work was approved by the human research ethics committee at the University of Wollongong (HE 13/401). 
4.2.3 MALDI-MS 
For MALDI-MS analysis, the methods are as described in Section 2.1.6 and Section 3.2. In brief, lenses 
were sliced in the transverse plane to produce 20 µm thick slices that were then thaw-mounted onto a glass 
slide and dried in a desiccator for 10 minutes prior to sublimation. Matrix was sublimed at 30 mTorr and 
112 ºC for 15 minutes. Samples were analysed by an LTQ-Orbitrap XL (ThermoScientific, Australia) with 
a MALDI source. The laser raster step size was set to 100 µm and an average of 50 laser shots produced a 
spectrum from each spot. The mass spectra were acquired in negative ion mode. The mass resolution at m/z 
400 was 33000 and the mass range acquired was m/z 400-2000. Lipids were identified based on accurate 
mass, with an error (Δ) of ± 3 ppm. MS imaging data were visualised by ImageQuest 1.0 (ThermoScientific, 
Australia). Images of the selected m/z values were normalized to the total ion current (TIC).  
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4.3 Results and Discussion 
4.3.1 MALDI-MS Images of Phosphatidylethanolamine in Human Lens 
The most abundant PEs in the human lens contain 1-O-alkyl ether linkages at the sn-1 position.7 Figure 
4.2a and b show the distribution of the lysophosphatidylethanolamine (LPE) and PE species in a 51 year-
old and 67 year-old human lens, respectively. Their identities were assigned based on accurate mass and 
previous identification in the human lens.7 A total of 15 species of PE (see Supplementary Figure S 4.1) 
and four species of LPE were detected in both human lenses. 
 
Figure 4.2: (a) Distribution of lyso-PE in a 51-year old and 67 year-old human lens. (b) Distribution of the 
most abundant PEs in a 51-year old and 67 year-old human lens. 
Figure 4.2a shows that different species of LPEs are present in both the cortex and the nuclear regions in 
both lenses. Most of the LPE species have a higher relative intensity in the nucleus. This observation is 
more pronounced in the 51 year-old lens in comparison to the 67 year-old lens. The abundance of LPE 
(18:1p) in the 51-year old lens is significantly lower than the other three species in the same lens, which 
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was confirmed by quantification data (3% of total LPE in the lens) in Chapter 5, Table 5.3. 
The diacyl PE species are located in an annular ring around the outer region of the lens (Figure 4.2b). This 
is in agreement with what has been observed previously in our lab.18 PE (18:1e/18:1) is the most abundant 
PE in the human lens, which contributes about 40% to the total PE detected in the lens.7 PE (18:1p/18:1), 
like its lyso analogue, was lower in abundance compared to other PEs. There was no PE (18:0e/18:1) 
detected in the 67 year-old lens. A previous study in our lab has shown that PE is approximately 1000-fold 
higher in intensity at the outer region in comparison to the nuclear or barrier regions.18 
Interestingly, PE (16:0e/18:1) and PE (18:1e/18:1) and their respective LPE analogues showed a 
complementary distribution, i.e. PE were detected at higher abundance in the outer region and LPE were 
detected at higher abundance in the core. Previous study by Ellis et al. using DESI for human lens lipid 
imaging has obtained similar results where PE was imaged around the outer ring of the lens while LPE was 
detected around the inner circle of PE in the cortex area.18 The difference in the images observed between 
our studies is that Ellis et al. did not observe LPE in the nuclear region. As the older lens nucleus contains 
more compact fibre cells which causes its consistency to be harder as compared to the cortex,19 it is possible 
that the spray solvent used in DESI were not able to fully desorb the nuclear region resulting in less LPE to 
be observed in the nucleus. 
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4.3.2 MALDI-MS Images of Phosphatidic Acid and Phosphatidylserine in Human Lens 
 
Figure 4.3: Distribution images of PA and PS in a 51-year-old and 67-year-old human lens. All the lipids 
were detected with [M-H]- in negative ion mode. 
The distribution of PA and PS are shown in Figure 4.3. Figure 4.3a shows the distribution of PA in the 
human lens. PA (16:0e/18:1) showed an annular distribution around the outer region of the 51-year-old 
lens. The same PA species showed a similar distribution around the outer region in the 67 year-old lens, 
however, it does not form a distinct ring as observed in the 51 year-old lens. In contrast, PA (18:0e/18:1) 
showed a more homogeneous distribution in the cortex, with a higher intensity around the edge of the 51-
year-old lens and a lower intensity in the nucleus. In the 67-year-old lens, the distribution of this PA lipid 
is similar, however it does not show as much difference in the intensity between the outer edge and the 
nucleus as compared to the 51-year-old lens. PA is the precursor for the biosynthesis of all phospholipids 
in mammals, thus the localisation of these lipids in the outer, metabolically active region of the human lens 
enables the potential conversion of PA to other phospholipids.20 Previous work done in our lab using DESI-
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TLC-MS has detected PA in the human lens.9  
The distribution of seven species of PS in the human lens were obtained using this method and are shown 
in Supplementary Figure S 4.2. The distribution of two abundant species, PS (16:0e/18:1) and PS 
(18:1e/18:1),7 is shown in Figure 4.3b. Both PS species showed a ring distribution around the outer edge of 
the lens in the 51 and 67 year-old lens. This agrees with the distribution pattern observed by Ellis et al. 
using DESI imaging.18  
4.4 Conclusion 
This study has demonstrated that MALDI-MS is a powerful tool that can be used to observe the localisation 
of different GPs in the human lens. GPs present in an adult lens were primarily detected in the cortex except 
for LPE. This is in agreement with previous quantitative work from our group where GPs in the nucleus 
were depleted in an adult lens after the age of 40.13 LPE showed a higher relative abundance in the nucleus 
of the lens in comparison to its PE analogue, which agrees with work indicating that LPE concentration is 
4-5 fold higher than PE in the adult lens nucleus.13  
GPs are more susceptible to oxidation and degradation compared to sphingolipids.21 There is no lipid 
turnover in the human lens nucleus,3 a consequence of which is the degradation of GPs observed with age.22 
This increases the ratio of SL to GPs, which is known to protect against further oxidation and degradation.21 
In combination with previous imaging studies of sphingolipids in the human lens, we have now obtained 
spatial distribution data for the majority of the lipids present in an adult human lens. The spatial distribution 
data provided by imaging mass spectrometry reveals the location of different lipids in different regions of 
a healthy adult human lens. This data can be used to supplement current knowledge about lens protein 
distribution to better understand the interaction between lens proteins and lens lipids that contribute to lens 
cellular function. Further studies to determine the abundance of these lipids, or the changes of their 
distribution with age are required in order to understand the role of these lipids in different regions of the 
lens.  
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4.5 Supplementary 
 
Figure S 4.1: Distribution of all PE species in a 51- and 67-year old human lens. 
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Figure S 4.2: Distribution of all PS species in a 51- and 67-year old human lens. 
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Abstract 
The human lens consist of four regions (outer, barrier, inner and core) according to the tissue formed during 
different stages of life (adult, childhood, infantile, in utero, respectively). Previous studies examining lens 
lipids were performed using whole lens homogenates or lenses divided into nucleus and cortex only. 
However, information on the lipid composition in different regions of the lens is essential to understand the 
development of the barrier, which develops at the nucleus-cortex interface at middle age and prevents 
diffusion of molecules such as antioxidants into and out of the nucleus. In this study, lipids were quantified 
in each region of the lens over the human lifespan. It was revealed that the lipid composition in each lens 
region is different, for example, glycerophospholipids were found to have a higher abundance in the outer 
and barrier regions of the lens, while sphingolipids were found to have a higher abundance in the lens inner 
and core regions. Some lipid classes, such as dihydrolactosylceramides did not change with age whilst of 
those that did, glycerophospholipids decreased in concentration with age and sphingolipids increased in 
concentration with age. The sudden increase in ceramide and dihydroceramide levels in the nucleus after 
the age of 40 as previously observed was also observed in this study. Interestingly, the current data shows 
that this increase is consistent across all lens regions. It was also identified that age-related alterations in 
lipid abundances are most prevalent in the barrier region of the human lens, indicating a possible link 
between membrane alterations and barrier formation. This study provides the most comprehensive data 
describing age-related alterations to the human lens lipidome to-date. This information is essential in linking 
the age-related changes of other biomolecules in the lens (e.g. proteins) to help understand the onset of eye 
diseases such as cataract. 
Keywords 
Barrier region, electrospray ionisation mass spectrometry, glycerophospholipid, sphingolipid, human lens. 
Abbreviations 
butylated hydroxytoluene (BHT), ceramide (Cer), ceramide phosphate (CerP), dihydroceramide (DHCer), 
dihydroceramidephosphate (DHCerP), dihydrolactosylceramide (DHLacCer), dihydrolactosylceramide 
sulfate (DHSM3), dihydromonosialodihexosylganglioside (DHGM3), dihydrosialyl Lewis acid (DHSialyl-
Lex), dihydrosphingomyelin (DHSM), dihydrosulfatide (DHST), dihydrotrihexosylceramide 
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(DHTriHexCer), generalised additive models (GAM), glycerophospholipid (GP), glycosphingolipids 
(GSL), lactosylceramide sulfate (SM3), lysophospholipidethanolamine (LPE), methyl-tert-butyl ether 
(MTBE), monosialodihexosylganglioside (GM3), dihydromonosialotetrahexosylganglioside (DHGM1), 
monosialotetrahexosylganglioside (GM1), phosphatidic acid (PA), phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), sphingomyelin (SM), sulfatide (ST). 
5.1 Introduction 
The human lens grows continuously throughout a human’s life span as new fibre cells are stacked on top 
of the pre-existing lens at birth.1 The lens can be divided into four regions that represent the four 
developmental stages of the lens i.e., the embryonic nucleus (core), infantile nucleus (inner), tissue formed 
in childhood (barrier), and newly synthesized cortical tissue (outer).2-5 There is no lens fibre cell turnover 
once mature fibre cells are formed.6 This is an important factor to consider when investigating the impact 
of ageing on the lens and the evolution of age-related nuclear cataract. Since there is a lack of protein6 and 
lipid7 turnover in the nucleus of the lens, the lens itself is a good model to investigate lipid stability over 
time. 
Previous literature suggests that the lens lipid composition changes with age e.g.,  increased concentrations 
of lipid oxidation products8 and complex glycosphingolipids such as gangliosides.9, 10 The majority of these 
studies have used whole lens homogenates to examine age-related changes in the lens lipidome,8, 9, 11-13 
which analyses both the old and newer lipids that are synthesized after birth together. Therefore, age-related 
results are difficult to interpret as the “age” of a particular lipid differs greatly across regions. A recent 
study on age-related degradation of lipid in the lens nucleus has shown that sphingomyelin (SM) and 
dihydrosphingomyelin (DHSM) levels in the lens nucleus remain constant over the lifespan of an individual 
while ceramides (Cer) and dihydroceramides (DHCer) increase dramatically in concentration between the 
ages of 30 and 60.14 The reason behind these changes remains unanswered. As there is no enzymatic activity 
in the lens nucleus that would synthesise ceramide,6, 7 it is likely that this increase results from the 
degradation of more complex sphingolipids. 
Studies performed in the 1960’s have identified various glycosphingolipids (GSL) and gangliosides present 
in human and rhesus monkey lenses.9, 10, 15-18 They were proposed to comprise <1% total lens lipid, but 
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played an important role in lens epithelial cell differentiation and maturation to fibre cells.17 Other 
sphingolipids, such as lactosylceramide sulfate (SM3) and sulfatides (ST) have also been identified in the 
human lens recently.19 It is clear that the previous quantification of the lens lipidome is insufficient as many 
other classes of glycosphingolipids such as dihydrolactosylceramide (DHLacCer) and gangliosides remain 
unquantified across the different regions of the lens. 
Given the different age of fibre cells within each lens region and the role of age-related changes in lipid and 
protein composition in the development of cataract20 and presbyopia21 it is essential to elucidate the 
complete lipid profile in different regions of the lens and study their changes with age. Accordingly, the 
aim of this study was to characterise the changes in lipid profile in the core, inner, barrier and outer regions 
of the human lens with age.  
5.2 Materials and Methods 
5.2.1 Materials 
MTBE, chloroform and methanol were HPLC grade and purchased from Thermo Scientific (Scoresby, 
VIC, Australia). Analytical grade butylated hydroxytoluene (BHT) and sodium hydroxide (98% minimum) 
where purchased from Sigma Aldrich (Sydney, NSW, Australia). Analytical grade ammonium acetate was 
purchased from Crown Scientific (Moorebank, NSW, Australia). Screw thread vials (4 mL) and 1.8 mL 
wide mouth vials (both with PTFE/silicone septa caps) were purchased from Grace Davison (Rowville, 
VIC, Australia). Lipid standards were synthesized by Avanti Polar Lipids (Alabaster, USA) except for 
deuterated monosialotetrahexosylganglioside (GM1) and monosialodihexosylganglioside (GM3), which 
were purchased from Matreya LLC (Pennsylvania, USA). 
5.2.2 Lenses 
Human lenses were obtained from eyes donated to the NSW Lions Eye Bank at the Sydney Eye Hospital, 
(Sydney, Australia) within 2–6 hours of death, and were stored immediately at -80 °C until required. All 
work was approved by the human research ethics committee at the University of Wollongong (HE 13/401). 
Table 5.3 shows the age and tissue weight of each region of the lenses used in this study. 
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Table 5.1: Age and tissue weight of each region of the lenses used in this study. O: outer region, B: barrier 
region, I: inner region, C: core region. 
Lens age (years) 
Tissue weight (mg) 
Outer Barrier Inner Core 
8 0 60.1 21.4 29.2 
9 0 48.8 18.8 61.7 
16 0 43.2 16.5 37.9 
19 0 3.4 19.6 25 
23 0 14 22.9 33.4 
27 0 32.3 30 30.2 
31 0 26.4 22.3 36.9 
38 9.3 25.7 22.6 35.9 
43 39.6 40.6 24.5 36.8 
48 3.3 26.6 25.9 57.8 
50 21.6 52.5 25.4 48.7 
55 38.5 27.3 20.5 43 
62 5.4 15.4 23.9 33.6 
66 16.2 53.4 32.6 56.1 
70 30.6 53.7 13.2 34.6 
74 23.5 46.2 21.6 34.5 
 
5.2.3 Lipid Extraction 
Sixteen lenses between the ages of 8 and 74 were dissected as described in Chapter 2.2.1.3. No technical 
replicates were run due to the limited sample volume extracted. Trephines with diameters of 8, 6, and 4.5 
mm were used to dissect lenses into the outer (>8 mm), barrier (8–6 mm), inner (6–4.5mm), and core (4.5 
mm) regions, respectively (Figure 2.10).  
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Figure 5.1: Illustration of the four regions of the lens obtained by dissection.3 
Immediately following dissection, all regions were weighed and total lipids extracted using methyl-tert-
butyl ether (MTBE) with mechanical bead homogenisation as described elsewhere.22, 23 In brief, tissue was 
added to homogenisation vials (Geneworks, Hindmarsh, SA, Australia) with ceramic beads, 300 μL of 
methanol containing 0.01 % BHT and 50 μL of an internal standard mixture (Table 5.2). The tissue was 
homogenised with a mechanical bead homogenizer (FastPrep-24, MP Biomedical, Seven Hills, NSW, 
Australia) at 6 m/s for 40 seconds, then transferred to a glass vial. 100 μL MeOH + 0.01% BHT was used 
to wash the beads before combining the wash with the homogenate. 920 μL of MTBE was added to the 
homogenate and rotated overnight at 4 °C. Following this, 230 μL of 150 mM ammonium acetate was added 
to the homogenate and vortexed for 20 seconds. The homogenate was then centrifuged for 5 minutes at 
2000 g to complete phase separation. The top phase containing MTBE and extracted lipids (~900 μL) was 
transferred to a new glass vial without disturbing the lower aqueous phase. Samples were dried under a 
stream of nitrogen at 37 °C, resuspended in 1:2 chloroform:methanol and stored at -20 °C. Prior to ESI-MS 
analysis, extracts were diluted 10-fold in 2:1 methanol:chloroform + 1 mM ammonium acetate. 
 
5.2.4 Mass Spectrometry 
All mass spectra were obtained using a LTQ-Orbitrap XL mass spectrometer (ThermoScientific, Australia) 
equipped with an electrospray ion source. Capillary voltage was set to -50 V, capillary temperature 250 °C 
and tube lens voltage -175 V. Sheath gas was set to 17, auxillary and sweep gas were turned off, and spray 
voltage was set to 4.5 kV. Multipole 00, multipole 0 and multipole 1 were set to 4 V, 4.5 V and 8 V, 
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respectively. Lens 0, lens 1 and gate lens voltage were set to 4.2 V, 15 V and 35 V, respectively. Multipole 
RF amplitude was set to 400 (V p-p) and front lens voltage was set to 5.25 V. Diluted lipid extracts were 
infused into the electrospray ion source at a flow rate of 5 μL.min-1 with a maximum injection time of 200 
ms. Mass spectra were acquired in negative mode with an average of 50 microscans with mass resolution 
of 100,000. Lipids were identified according to accurate mass (< 3 ppm) with a signal to noise ratio of 5:1. 
However, sugar groups were not specifically characterised in this study with GSL identities assigned based 
on previous identification in the human lens.15, 16, 24 All lipids were detected as [M+Cl]- or [M-H]- ions (See 
supplementary Table S 5.1 and Table S 5.2 for details).  
Lipids were quantified by averaging 50 MS scans in negative ion mode and the peak intensity of each lipid 
was obtained. Following isotope correction, the ion abundance for each lipid was normalised to the 
appropriate internal standard (Table 5.2), and multiplied by the known concentration of that internal 
standard (nmol.g (tissue)-1). Lipid classes with no commercially available standard were quantified using 
an internal standard with the closest chemical properties. The internal standard used for each lipid class is 
shown in Table 5.2. All lipid species were summed to give a total lipid of each class in the different regions 
of the lens. 
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Table 5.2: Lipid standard used to quantify each lipid class and its concentration in the internal standard 
mixture. 
Lipid Class Lipid Standard  Concentration (μM) 
LPE LPE 14:0 20 
PA PA (17:0/17:0) 20 
PE PE (17:0/17:0) 20 
PC PC (19:0/19:0) 30 
SM 
DHSM 12:0 85 
DHSM 
Cer  Cer 12:0 25 
DHCer  DHCer 12:0 25 
CerP 
CerP 12:0 30 
DHCerP 
DHLacCer 
LacCer 12:0 30 
DHTriHexCer 
ST 
ST 12:0 30 
DHST 
SM3 
DHSM3 
DHGM3 GM3 17:0-CD3 20 
DHGM1 GM1 17:0-CD3 30 
DHSialyl-Lex GM3 17:0-CD3 20 
 
LPE: lysophospholipidethanolamine, PA: phosphatidic acid, PE: phosphatidylethanolamine, PC: 
phosphatidylcholine, SM: sphingomyelin, DHSM: dihydrosphingomyelin, Cer: ceramide, DHCer: 
dihydroceramide, CerP: ceramide phosphate, DHCerP: dihydroceramidephosphate, DHLacCer: 
dihydrolactosylceramide, DHTriHexCer: dihydrotrihexosylceramide, ST: sulfatide, DHST: 
dihydrosulfatide, SM3: lactosylceramide sulfate, DHSM3: dihydrolactosylceramide sulfate, DHGM3: 
dihydromonosialodihexosylganglioside, DHGM1: monosialotetrahexosylganglioside, DHSialyl-Lex: 
dihydrosialyl Lewis acid. 
 
5.2.5 Nomenclature 
In this paper glycerophospholipids (GPs) and sphingolipids will adopt the abbreviations of Fahy et al.25 1-
O-alkyl ether and 1-O-alkenyl ether lipids will have the abbreviation of “O-” before the fatty acyl chains.  
5.2.6 Statistical Analysis 
As the change in concentration with age was nonlinear for most lipids, generalised additive models (GAM) 
were fit to the data. GAM is an extension of generalised linear models with a smoothing function.26 It helps 
to predict a model that is not totally linear by applying a smoothing term. The solid line in all figures 
corresponds to the GAM fit while dashed lines show the 95% confidence interval for the fit. All 
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computations were performed using R version 3.4.10 (R Core Team 2009) with extension package mgcv. 
5.3 Results and Discussion 
In this study 94 lipids species were detected in the human lens using ESI-MS. This includes 6 classes of 
SL, 9 classes of GSLs and 4 classes of GPs. A full list of individual lipids detected is shown in 
Supplementary tables S 5.1 and S 5.2. A comparison of the percentage distribution of each lipid class in the 
core, inner, barrier and outer region of human lenses is shown in Table 5.3. 
Table 5.3: Comparison of the percentage distribution of lipid classes in the core, inner, barrier and outer 
region of human lenses. Data are presented as mean ± SEM. n=16 for the core, inner and barrier regions, 
n=10 for the outer region. 
Lipid Class 
Percentage of total lipid (%) 
Core Inner Barrier Outer 
G
P
 
LPE 5.78 ± 0.50 4.53 ± 0.35 3.28 ± 0.24 3.04 ± 0.39 
PA 0.46 ± 0.13 0.59 ± 0.18 1.00 ± 0.20 0.89 ± 0.27 
PE 13.1 ± 2.99 21.8 ± 3.33 25.06 ± 2.28 28.19 ± 2.45 
PC 1.30 ± 0.38 3.70 ± 0.86 6.95 ± 1.63 9.05 ± 2.28 
Total 20.64 ± 2.89 30.62 ± 4.79 36.29 ± 5.47 41.17 ± 6.21 
S
L
 
SM 6.54 ± 0.46 8.18 ± 0.62 8.54 ± 0.52 8.77 ± 0.76 
DHSM 34.35 ± 1.45 35.41 ± 1.87 30.55 ± 1.12 30.01 ± 2.60 
Cer 2.73 ± 0.74 1.33 ± 0.43 0.48 ± 0.18 0.65 ± 0.37 
DHCer 8.79 ± 2.20 3.74 ± 1.12 0.93 ± 0.34 0.6 ± 0.21 
CerP 2.48 ± 0.44 1.91 ± 0.50 2.52 ± 0.48 2.46 ± 0.75 
DHCerP 10.34 ± 1.69 7.22 ± 1.89 7.80 ± 1.43 6.14 ± 1.32 
Total 65.23 ± 4.87 57.8 ± 5.68 50.81 ± 4.63 48.62 ± 4.57 
G
S
L
 
DHLacCer 4.19 ± 0.25 2.27 ± 0.19 1.25 ± 0.09 0.85 ± 0.08 
DHTriHexCer 0.73 ± 0.11 0.49 ± 0.06 0.41 ± 0.05 0.36 ± 0.09 
ST 0.02 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.07 ± 0.02 
DHST 0.06 ± 0.01 0.10 ± 0.01 0.12 ± 0.01 0.13 ± 0.02 
SM3 0.06 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.02 
DHSM3 0.24 ± 0.02 0.24 ± 0.03 0.23 ± 0.02 0.21 ± 0.02 
DHGM3 7.13 ± 0.91 5.83 ± 0.65 8.51 ± 1.00 6.73 ± 0.55 
DHGM1 1.49 ± 0.49 2.36 ± 0.91 2.14 ± 0.68 1.75 ± 0.41 
DHSialyl-
LeX 
0.20 ± 0.04 0.18 ± 0.05 0.11 ± 0.03 0.05 ± 0.02 
Total 14.13 ± 0.83 11.58 ± 0.65 12.9 ± 0.92 10.21 ± 0.72 
LPE: lysophospholipidethanolamine, PA: phosphatidic acid, PE: phosphatidylethanolamine, PC: 
phosphatidylcholine, SM: sphingomyelin, DHSM: dihydrosphingomyelin, Cer: ceramide, DHCer: 
dihydroceramide, CerP: ceramide phosphate, DHCerP: dihydroceramidephosphate, DHLacCer: 
dihydrolactosylceramide, DHTriHexCer: dihydrotrihexosylceramide, ST: sulfatide, DHST: 
dihydrosulfatide, SM3: lactosylceramide sulfate, DHSM3: dihydrolactosylceramide sulfate, DHGM3: 
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dihydromonosialodihexosylganglioside, DHGM1: monosialotetrahexosylganglioside, DHSialyl-Lex: 
dihydrosialyl Lewis acid 
5.3.1 Core Region 
Phosphatidylethanolamine (PE) was the most abundant GP class in the human lens core, contributing 13.1% 
of total lipid and 63.5% of total GP (Table 5.3). As shown in Table 2, lysophosphatidylethanolamine (LPE) 
was also a major GP class in the lens core (28% of total GP), with phosphatidylcholine (PC) and 
phosphatidic acid (PA) detected at much lower levels. Of the molecular phospholipids in the core PE (O-
36:2) was the most abundant species contributing 7.6% of total GP (Supplementary Table S 5.1). These 
findings agree with previous studies for the most part,14, 27, 28 however, data from Hughes et al. suggests 
that LPE levels are considerably higher at almost 50% of total GP.14 Nevertheless, the current LPE data is 
in agreement with another previous study,29 which suggests that the correction factor used by Hughes and 
colleagues to adjust for differences in fragmentation between LPE and the PE internal standard may have 
been overestimated. 
The most abundant SL class in the human lens core was DHSM, which contributed 34.4% of total lipid 
measured in the core (Table 5.3). As shown in Table 5.3, dihydroceramide phosphate (DHCerP) (10.3%) 
and DHCer (8.8%) were also a major SLs in the lens core, with their analogues comprising a sphingosine 
backbone at much lower levels. Of the SLs in the core, DHSM 16:0 was the most abundant SL which 
accounts for 58% of total DHSM followed by DHSM 24:1 (30%) (Table 5.2). This agrees with previous 
studies and applies for all the SL in the lens where the two most abundant species are those with a 
sphinganine backbone and a 16:0 or 24:1 fatty amide.14, 19, 27, 30 ). Interestingly, both DHLacCer 16:0 and 
DHLacCer 24:1 were very similar in abundance (~ 49% and ~ 40% of total DHLacCer, respectively), which 
was different from other SL classes mentioned previously, where the 16:0 analogue had a higher abundance 
than the 24:1 analogue. For example DHSM 16:0 was approximately 28% higher in abundance than DHSM 
24:1 while DHCer 16:0 was approximately 25% higher in abundance than DHCer 24:1.  
Total GSLs in the core comprised about 14.1% of total lipid (Table 5.3). 
Dihydromonosialodihexosylganglioside (DHGM3) (7.1%) was the most abundant GSL class in the core 
region, followed by DHLacCer (4.2%) and dihydromonosialotetrahexosylganglioside (DHGM1) (1.5%). 
As shown in Table 5.3, the rest of the GSLs were of very low abundance in the lens core, with sulfo-GSLs 
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such as ST abundance being as low as 0.02%.  
5.3.2 Inner Region 
The inner region of the lens is comprised of fibre cells that were laid down immediately after birth.3, 31, 32 
Total GP in inner region of the human lens was 30.6%. PE was the most abundant GP class in the inner 
region accounting for 21.8% of total lipid, followed by LPE at 4.5% and PC at 3.7%. PA was the least 
abundant GP class at 0.6%. 
Total SL in the inner region of the lens was 57.8% of total lipid. DHSM was the most abundant SL (35.4%) 
in the inner region of the lens (Table 5.3). Cer and DHCer accounted for 1.3% and 3.7% of total lipid in the 
inner region of the lens, respectively (Table 5.3). Meanwhile, ceramide phosphate (CerP) and DHCerP 
levels in the inner region were around 1.9% and 7.2% of total lipid, respectively (Table 5.3). 
DHGM3 (5.8%) was the most abundant GSL, followed by DHGM1 (2.4%) and DHLacCer (2.3%). 
Dihydrotrihexosylceramide (DHTriHexCer) and dihydrosialyl Lewis acid (DHSialyl-Lex) comprised 0.5% 
and 0.2% of total lipid in the inner region. The sulfo-GSLs such as SM3, dihydrosulfatide (DHST), and ST 
had negligible abundance in total lipid with less than 0.1% each except for dihydrolactosylceramide sulfate 
(DHSM3) (0.2%). 
5.3.3 Barrier Region 
The barrier region is part of the lens cortex, with its cells laid down during childhood years. The GP content 
in the barrier region is 36.3% as shown in Table 5.3. PE was the most abundant GP in the barrier region at 
25.1% of total lipid, followed by PC (6.9%), LPE (3.3%) and PA (1%). The most abundant PC in the lens 
was PC (34:1), which contributed ~ 35% to total PC. This is in agreement with previous quantification by 
Deeley et al. and Hughes et al. where the most abundant PC is assigned as PC (16:0/18:1).14, 27 
The most abundant SL in the barrier region of the human lens was DHSM (30.6%), as shown in Table 5.3. 
It was followed by SM (8.5%), DHCerP (7.8%) and CerP (2.5%).  Cer and DHCer in the barrier region 
were less than 1% each. DHGM3 (8.5%) was the most abundant GSL class followed by DHGM1 (2.1%) 
and DHLacCer (1.3%) (Table 5.3). Total sulfo-GSLs (ST+ DHST+SM3+DHSM3) in the barrier region 
was 0.5%, with DHTriHexCer accounted for 0.4% and DHSialyl-Lex at 0.1% of total lipid. 
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5.3.4 Outer Region 
There were only 10 samples in the outer region as the young lenses were relatively smaller in size (not more 
than 8mm), thus there was no outer region tissue obtained for lenses from age 8 to 30). PE was the most 
abundant GP class in the outer region of human lens, contributing 28.2% of total lipid and 68.5% of total 
GP (Table 5.3). As shown in Table 5.2, PC was also a major GP class in the lens outer region (21.9% of 
total GP), with LPE and PA detected at much lower levels. 
The most abundant SL in the outer region was DHSM (30.0%) as shown in Table 5.3. This is followed by 
SM and DHCerP which accounted for 8.8% and 6.1% of total lipid in the outer region, respectively. Cer 
and DHCer had the lowest abundance in this region (< 1%). GSLs in the outer region accounted for 10.2% 
of total lipid. DHGM3 was the most abundant GSL class, contributing 6.7% of total lipid followed by 
DHGM1 (1.8%). The rest of the GSLs were less than 1% each.  
5.3.5 Comparison Across Lens Regions 
This is the first study to quantify some of the SLs (CerP and DHCerP) and GSLs (DHLacCer, 
DHTriHexCer, ST, DHST, SM3 and DHSM3) in different lens regions. This work demonstrates that the 
lipid composition of different regions in the lens can vary. The outer region was comprised of the highest 
percentage of GPs at 41.2% of total lipid in all regions of the lens (Table 5.3). It was observed that the GP 
content decreases as the lens fibre cells get older (from cortex to nucleus). This may be due to the lack of 
metabolic pathways in the lens core. Subsequently, this lack of repair mechanisms results in the degradation 
of GPs over time.33-35 PA remained as the GP with the lowest abundance in all regions. PE was the most 
abundant lipid class of all GPs across each region of the lens. Total PE levels were twice as high in the 
outer region compared to core of the lens (28.2% vs. 13.1%). The relative percentage of PE increased from 
the core towards the outer region, in contrast to the percentage of LPE, which decreased from the core 
towards the outer region. This is contrary to previous observations of LPE abundance by DESI-MSI, which 
was higher in the barrier/inner cortex region of the human lens than in the nucleus.36 However, the data 
obtained from imaging an individual lens slice may not be a true representation of the lipid abundance of 
an entire region. The abundance of PC was also highest in the outer region at 9.1% of total lipid.  
SL levels were highest in the lens core and lowest in the outer region of the lens. This may be due to the 
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low oxidative susceptibility of SLs in the lens nucleus.6, 7 DHSM represented the most abundant lipid in all 
regions of the lens. Both Cer and DHCer percentages decreased gradually from the core towards the outer 
region. In the barrier and outer regions, both of these lipids abundances were less than 1%. This is in 
agreement with our previous imaging data (Chapter 3, Figure 3.3) where the distribution of Cer and DHCer 
were concentrated in the lens nucleus only.  
The most abundant GSL in all regions of the lens was DHGM3. Both DHLacCer and DHTriHexCer showed 
a decrease in percentage from the lens core towards the outer region. DHLacCer abundance in the inner 
region was about half its abundance in the core (2.3% and 4.2% respectively). DHSM3 and SM had similar 
relative abundances across all regions of the lens, while the percentage of both ST and DHST increased 
from the core towards the outer region. DHST 16:0 was more abundant than DHST 24:1, however, for ST, 
SM3 and DHSM3, their 24:1 analogue was more abundant than their 16:0 analogues. As opposed to DHST, 
DHSialyl-Lex showed a decrease in relative abundance from the core towards the outer region. This is in 
agreement with our previous imaging data (Chapter 3, Figure 3.5), which showed that both ST and DHST 
were present in the outer region of the lens where as DHSialyl-Lex was present in the nucleus. The 
gangliosides in the lens were predominated by 16:0 and 24:1 fatty acids, which agreed with previous 
literature.37 In our study, all gangliosides in the lens had a higher abundance of long chain monounsaturated 
24:1 analogues in comparison to their 16:0 analogue. This is in agreement with previous observation by 
Tao and co-workers.38  
5.3.6 Age-related Changes in Lipids 
5.3.6.1 Core Region 
As shown in Figure 5.2a, PE decreased in abundance in adolescent lenses and started to plateau around 30-
50 years of age before declining again as observed previously.14 Conversely, no age-related changes were 
observed for LPE, PA or PC (see Supplementary Figure S 5.1). This is in contrast to a previous observation 
of decreases in PC and LPE abundance with age by Hughes et al.14 This may be due to a smaller number 
of samples below the age of 20 in our experiment, which contained a higher abundance of PC and high 
variability in lipid concentration between lenses. 
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Figure 5.2: Total (a) PE; (b) Cer and (c) DHCer present in the core region of human lenses of different 
ages. All values are expressed in nmol/g tissue wet weight. The solid line is a generalised additive model 
fit; the dashed lines give a 95% confidence band. The green line corresponds to the mean of the data. PE: 
phosphatidylethanolamine, Cer: ceramide, DHCer: dihydroceramide. 
Data from the current study regarding changes to Cer and DHCer concentrations with age demonstrates 
similar patterns to previous reports.14 It was observed that Cer and DHCer that were almost undetectable in 
the adolescent lens (0-6 nmol/g) increased suddenly in concentration from age 40 onwards (Figure 5.2b and 
c). DHCer increased 1100-fold (~1100 nmol/g) from adolescence whereas Cer increased approximately 
350-fold (~350 nmol/g) from adolescence. The reason for this pronounced change remains unkown. No 
age-related changes in DHSM, SM, CerP or DHCerP were observed in the lens core (Supplementary Figure 
S 5.2). While age-related changes in CerP and DHCerP levels have not previously been investigated the 
DHSM and SM data agree with previous findings.14 
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Regardless of age, the presence of the same GSL classes in the lens core was observed. This is in agreement 
with an age-related study by Ogiso et al. where they observed that the ganglioside composition was constant 
for whole human lens homogenates between 16 – 80 years.10 Our data also suggest that there are no age-
related changes in any GSL class in the core region of the lens (see Supplementary Figure S 5.3). Although 
Ogiso et al. observed that DHGM3 and DHGM1 levels accumulated with ageing and cataract progressing 
lenses, this may be due to their study using whole lenses and therefore cannot be compared to the lens core 
where there is no lipid turnover.7, 10 
5.3.6.2 Inner Region 
Like the core region, most GP classes such as LPE, PA and PC showed no age-related effects changes in 
concentration (Supplementary Figure S 5.4). The only GP that displayed a different age-related effect to its 
core is PE, where it showed a more pronounced linear decrease in concentration with age (Figure 5.3a) in 
comparison to its core, where the decrease plateaus around middle age (Figure 5.2a). The total PE in the 
inner region decreased from approximately 3500 nmol/g at adolescent years to approximately 500 nmol/g 
at 70 years of age.  
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Figure 5.3: Total (a) PE; (b) SM, (c) DHSM, (d) Cer, (e) DHCer, (f) DHST, (g) SM3 and (h) DHGM1 
present in the inner region of human lenses of different ages. All values are expressed in nmol/g tissue wet 
weight. The solid line is a generalised additive model fit; the dashed lines give a 95% confidence band. The 
green line corresponds to the mean of the data. PE: phosphatidylethanolamine, SM: sphingomyelin, 
DHSM: dihydrosphingomyelin, Cer: ceramide, DHCer: dihydroceramide, DHST: dihydrosulfatide, SM3: 
lactosylceramide sulfate, DHGM1: monosialotetrahexosylganglioside. 
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Figure 5.3b and c show the age effect on the total concentration of SM and DHSM in the inner region of 
human lenses, respectively. An increase in the total concentration was observed for both SL with age in 
contrary to the core where no age-related change was observed. The relationship between Cer and DHCer 
with age is shown in Figure 5.3d and e, respectively. The trend for both Cer and DHCer is similar to what 
was observed in the lens core, where no traces of these lipids were found in adolescent lenses, but a sharp 
increase was observed after the age of 40 until old age. The amplitude of increase is also similar to the core, 
~ 400 nmol/g for Cer and ~ 1000 nmol/g for DHCer. No age-dependent effect on the concentration of CerP 
and DHCerP was observed (see Supplementary Figure S 5.4). 
SM3, DHST and DHGM1 abundance increased linearly with age, as shown in Figure 5.3f, g and h, 
respectively. No other GSLs displayed age-related changes in concentration in the inner region of the lens 
(Supplementary Figure S 5.5). 
5.3.6.3 Barrier Region 
Figure 5.4a and b show an age-related effect for total PE and PC abundance in the barrier region of human 
lenses, respectively. It was observed that PE concentration decreased with age in the barrier region, but this 
decrease was not as pronounced as that observed in the core and inner regions. The total abundance of PC 
decreased non-linearly with age as opposed to the lens nucleus (core and inner regions) where no age-
related effect was observed. PC decreased from ~1200 nmol/g to ~600 nmol/g from a young age until 40 
years and then plateaued. Other GPs such as LPE and PA did not show any changes with age 
(Supplementary Figure S 5.6). 
Figure 5.4c and d show that SM and DHSM levels increased in the barrier region with age, respectively. 
SM abundance increased until 20 years, then plateaued from 20 to 40 years before increasing again. 
Meanwhile, DHSM increased linearly with age in the human lens barrier. This is in agreement with a 
previous study that reported an increase of DHSM in the barrier region of older lens.30 
Similar to the core and inner region, Cer and DHCer were negligible in young lenses but showed a sharp 
increase after the age of 40 (as shown in Figure 5.4e and f, respectively). However, the increase is not as 
pronounced as that observed in the lens core and inner regions (250-fold and 400-fold vs. 1000-fold). CerP 
abundance increased linearly with age (Figure 4g) whereas its sphinganine analogue, DHCerP, did not show 
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any age-related changes in abundance (Supplementary Figure S 5.6). 
 
Figure 5.4: Total (a) PE; (b) PC, (c) SM, (d) DHSM, (e) Cer, (f) DHCer, (g) CerP present in the barrier 
region of human lenses of different ages. All values are expressed in nmol/g tissue wet weight. The solid 
line is a generalised additive model fit; the dashed lines give a 95% confidence band. The green line 
corresponds to the mean of the data. PE: phosphatidylethanolamine, PC: phosphatidylcholine, SM: 
sphingomyelin, DHSM: dihydrosphingomyelin, Cer: ceramide, DHCer: dihydroceramide, CerP: ceramide 
phosphate. 
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Of the GSLs, only sulfo-GSLs displayed age-related changes in the barrier region of the lens. A linear 
increase was observed for ST (Figure 5.5a) and DHST (Figure 5.5b) with age. ST increased from ~0 nmol/g 
to ~10 nmol/g from young to old age where DHST increased from ~5nmol/g to 20 nmol/g. SM3 and 
DHSM3 also increased in total abundance from young to old age (Figure 5.5c and d). Other GSLs did not 
show any age-related changes in abundance (see Supplementary Figure S 5.6). 
 
Figure 5.5: Total (a) ST; (b) DHST, (c) SM3, (d) DHSM3 present in the barrier region of human lenses of 
different ages. All values are expressed in nmol/g tissue wet weight. The solid line is a generalised additive 
model fit; the dashed lines give a 95% confidence band. The green line corresponds to the mean of the data. 
ST: sulfatide, DHST: dihydrosulfatide, SM3: lactosylceramide sulfate, DHSM3: dihydrolactosylceramide 
sulfate. 
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5.3.6.4 Outer Region 
There were no age-related changes observed in any GP class in the outer region (See Supplementary Figure 
S 5.7). Age-related effects on the total abundance of SM and DHCer are shown in Figure 5.6a and b, 
respectively. SM levels increased by approximately 400 nmol/g in lenses aged 50 and above (Figure 5.6a). 
On the other hand, DHCer levels gradually increased from age 50 to 70 by approximately 100 nmol/g. Due 
to the small sample size, many of the age-related effects on other SLs were difficult to determine (see 
Supplementary Figure S 5.7).  
Age-related effects on total ST and DHST abundance are shown in Figure 5.6c and d, respectively. Both 
ST and DHST abundance increased linearly from the age of 30. Similarly, age-related increases in SM3 
(Figure 5.6e) and DHSM3 (Figure 5.6f) were also observed. Although they are of relatively low abundance 
(~ 2 to 30 nmol/g) in comparison to other GSLs, these sulfo-GSLs showed a consistent age-related increase 
in abundance in the cortical cells of human lenses.  
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Figure 5.6: Total (a) SM; (b) DHCer; (c) ST; (d) DHST, (e) SM3, (f) DHSM3 present in the barrier region 
of human lenses of different ages. All values are expressed in nmol/g tissue wet weight. The solid line is a 
generalised additive model fit; the dashed lines give a 95% confidence band. The green line corresponds 
to the mean of the data. SM: sphingomyelin, DHCer: dihydroceramide, ST: sulfatide, DHST: 
dihydrosulfatide, SM3: lactosylceramide sulfate, DHSM3: dihydrolactosylceramide sulfate. 
In this study, we demonstrated that the GP and SL composition in older human lenses varies from that of 
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younger individuals. Some classes of GPs and SLs remained constant throughout a human’s lifespan, 
whereas other GP classes decreased in concentration with age while some SL classes increased in 
abundance with age. With increasing age, an increase in total lipid content was observed in all regions 
(except the outer region where there is not enough data to make a comparison between young and old 
lenses). As there is no turnover of lipid,7 this may be due to the central compaction of lens fibre cells with 
age that leads to the alteration in packing density and membrane topology.39, 40 The core region has the least 
change in total wet weight of tissue, from 6.3 mg to 6.7 mg, whereas the inner region increases from 8.4 
mg to 9.0 mg. The largest increase in wet weight of lens tissue occurs in the barrier region from 9.1 mg to 
11.2 mg. A previous study has shown that age-related changes affecting the composition of lipid can be 
used as an oxidative stress marker.41 As the lens is packed with cholesterol, oxysterol levels in the lens 
increased with oxidative stress.41 Age-related compaction of fiber cells may also lead to higher oxidative 
stress in the lens.2 In this study, the presence of any oxidised lipids were not investigated as standards were 
not commercially available. 
Our observation of age-related changes in the lens core is similar to what has been observed previously.14 
Although the inner region is also a part of the lens nucleus, ageing affects more lipid classes in this region 
as compared to the core where only PE, Cer and DHCer changed with age. In addition to these three lipid 
classes, SM, DHSM, DHST, SM3 and DHGM1 also showed an increase with age in the inner region. The 
most age-related changes in lipid class abundance occurred in the barrier region. On the other hand, only 
six SLs showed an age-related effect in the outer region of the lens.   
In 1999, Moffat el al. observed a reduction in the amount of water entering the lens nucleus via the cortex 
and epithelium.42 This phenomenon could be due to the development of a barrier to the diffusion of water 
between the nucleus and cortex. Alterations to the diffusion of metabolic substances, nutrients, antioxidants 
and reactive molecules can cause antioxidants such as glutathione to be lower in concentration than the 
reactive species in the nucleus.20, 43 The formation of this barrier occurs around middle-age (around the age 
of 40),20, 42 where some GP classes were observed to have been depleted while SLs levels were increased. 
GPs and SLs are known to change either the water permeability of cell membranes,44 or the structure and 
function of important lens membrane proteins such as water or ion channels45 that may facilitate lens 
metabolite movement.  Alterations to the lipid composition of fibre cell membranes with age may therefore, 
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play a role in the development of this functional barrier. 
Although the literature suggests that gangliosides accumulate in conjunction with ageing and senile cataract 
progression,10 the current study found an increase of only one class of gangliosides, DHGM1, in the inner 
region. There are other gangliosides such as GD1a, III3FucnLc4 and other globo- and neolacto- species in 
the lens that were not detected and quantified in our study. Therefore, the increase of gangliosides in the 
previous study cannot be directly compared to the current work.9 Sulfo-GSLs such as ST, DHST, SM3 and 
DHSM3 showed a linear increase in all regions of the lens except the core. The age-related changes in GSLs 
may modify the cell-to-cell interactions induced by cell surface sugar chains, leading to the initiation and 
progression of cataract.46 
Although we have successfully quantified the majority of known lipids in different regions of the lens and 
examined their change in abundance with age, the reason behind the sharp rise in Cer and DHCer levels in 
all of the regions the lens remains unknown. None of the SL classes that are biosynthetically related to Cer 
and DHCer are large enough in abundance to account for the increase in these two lipid classes. In fact, 
most of the ceramide conjugates such as DHCerP and CerP also increased with age. Therefore, the 
hypothesis that the dramatic increase Cer and DHCer concentration were caused by the hydrolysis of other 
more complex sphingolipids must be rejected.  
5.4 Conclusion 
In summary, this study has produced several findings: (i) the lipid membrane composition is different in 
each region of the lens, (ii) GP content increases in abundance from the core towards the outer region, in 
contrast to SL abundance which decreases, (iii) the increase in Cer and DHCer after the age of 40 occurs in 
all regions of the lens, and (iv) most of the lipid classes were affected by age in the barrier region as 
compared to other regions. In addition, the most abundant SL molecule of each detected class were those 
with a 16:0 fatty acyl chain. For GSLs, however, their 24:1 analogues were of higher abundance (except 
DHST). This study provides the first insight into the composition of lens lipids categorised into three main 
groups of GP, SL and GSL in the four regions of the lens. If an age-related change was observed for any 
lipid class, that lipid class always displayed the same change (i.e., consistently increased or decreased) 
irrespective of the region. Although the best effort was put into elucidating and quantifying the full lens 
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sphingolipidome, some gangliosides that were previously identified such as GD1a were not included which 
may be due to its low abundance. However, this work has provided insight into the possibility of quantifying 
very low abundance GSLs (some were less than 0.1% of total lipid), and therefore future work may aim at 
optimising the quantification methods for these low abundance lipids that exist at a higher mass range.  
5.5 Supplementary  
Table S 5.1: List of phospholipid species detected in the human lens with their chemical formula and exact 
mass (neutral). All the lipids were identified by [M+Cl] - or [M-H] -. 
Glycerophospholipids 
  FA Chemical Formula m/z [M+Cl]-  
Phosphatidylcholine   
PC 30:0 C38H76NO8P 740.4997 
  31:0 C39H78NO8P 754.5154 
  32:1 C40H78NO8P 766.5154 
  32:0 C40H80NO8P 768.5310 
  O-34:0 C42H84NO7P 780.5674 
  34:2 C42H80NO8P 792.5310 
  34:1 C42H82NO8P 794.5467 
  O-36:2 C44H86NO7P 806.5830 
  36:4 C44H80NO8P 816.5310 
  36:3 C44H82NO8P 818.5467 
  36:2 C44H84NO8P 820.5623 
  36:1 C44H86NO8P 822.5780 
  38:5 C46H82NO8P 842.5467 
  38:4 C46H84NO8P 844.5623 
  
Phosphatidylethanolamine     m/z [M-H] - 
PE O-34:2 C39H76NO7P 700.5281 
  O-34:1 C39H78NO7P 702.5438 
  34:2 C39H74NO8P 714.5074 
  34:1 C39H76NO8P 716.5230 
  O-36:3 C41H78NO7P 726.5438 
  O-36:2 C41H80NO7P 728.5594 
  O-36:1 C41H82NO7P 730.5751 
  36:4 C41H74NO8P 738.5074 
  36:2 C41H78NO8P 742.5387 
  36:1 C41H80NO8P 744.5543 
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  O-38:6 C43H76NO7P 748.5281 
  O-38:5 C43H78NO7P 750.5438 
  O-38:4 C43H80NO7P 752.5594 
  38:5 C43H76NO8P 764.5230 
  38:4 C43H78NO8P 766.5387 
  O-40:8 C45H78NO7P 774.5438 
  O-40:6 C45H80NO7P 776.5594 
  O-40:5 C45H82NO7P 778.5751 
  
Phosphatidic Acid    m/z [M-H] - 
PA O-34:1 C37H73O7P 659.5016 
  O-36:1 C39H77O7P 687.5329 
  
Lyso lipids 
Phosphatidylethanolamine     m/z [M-H] - 
LPE 16:0e C21H46NO6P 438.2985 
  16:0 C21H44NO7P 452.2777 
  18:1p C23H46NO6P 462.2985 
  18:1e C23H48NO6P 464.2777 
  18:0e C23H50NO6P 466.3298 
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Table S 5.2: List of sphingolipid species detected in the human lens with their chemical formula and exact 
mass (neutral). All the lipids were identified by [M+Cl] - or [M-H] -. 
Sphingolipids 
  FA Chemical Formula m/z [M+Cl]- 
Sphingomyelin       
DHSM(d18:0) 14:0  C37H77N2O6P 711.5208 
  15:0 C38H79N2O6P 725.5364 
  16:0 C39H81N2O6P 739.5521 
  17:0 C40H83N2O6P 753.5677 
  18:0 C41H85N2O6P 767.5834 
  22:0 C45H93N2O6P  823.6460 
  24:1 C47H95N2O6P 849.6616 
  
SM(d18:1) 14:0 C37H75N2O6P 709.5051 
  15:0 C38H77N2O6P 723.5208 
  16:1 C39H77N2O6P 735.5208 
  16:0 C39H79N2O6P 737.5364 
  18:0 C41H83N2O6P 765.5677 
  22:1 C45H89N2O6P 819.6147 
  22:0 C45H91N2O6P 821.6303 
  23:0 C46H93N2O6P 835.6460 
  24:2 C47H91N2O6P 845.6303 
  24:1 C47H93N2O6P 847.6460 
  
Ceramide    m/z [M+Cl]- 
DHCer(d18:0) 14:0 C32H65NO3 546.4653 
  16:0 C34H69NO3 574.4966 
  22:1 C40H79NO3 656.5748 
  22:0 C40H81NO3 658.5905 
  24:1 C42H83NO3 684.6061 
  
Cer(d18:1) 14:0 C32H63NO3 544.4496 
  16:0 C34H67NO3 572.4809 
  22:1 C40H77NO3 654.5592 
  22:0 C40H79NO3 656.5748 
  24:1 C42H81NO3 682.5905 
  
Ceramide Phosphate    m/z [M-H] - 
DHCerP(d18:0) 16:0 C34H70NO6P 618.4863 
  24:1 C42H84NO6P 728.5958 
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CerP(d18:1) 16:0 C34H68NO6P 616.4706 
  24:1 C42H82NO6P 726.5802 
  
Lactosylceramide    m/z [M+Cl]- 
DHLacCer(d18:0) 16:0 C46H89NO13 898.6022 
  22:0 C52H101NO13 982.6961 
  24:1 C54H103NO13 1008.7118 
  24:0 C54H105NO13 1010.7274 
  
DHTrihexosylceramide (d18:0) 16:0 C52H99NO18 1060.6551 
  24:1 C60H113NO18 1170.7646 
  
Sulfatide    m/z [M-H] - 
DHST(d18:0) 14:0 C38H75NO11S 752.4983 
  16:0 C40H79NO11S 780.5296 
  24:1 C48H93NO11S 890.6391 
  
ST(d18:1) 14:0 C38H73NO11S 750.4826 
  16:0 C40H77NO11S 778.5139 
  24:1 C48H91NO11S 888.6235 
  
Lactosylceramide Sulfate     m/z [M-H] - 
DHSM3(d18:0) 14:0 C44H85NO16S 914.5511 
  16:0 C46H89NO16S 942.5824 
  24:1 C54H103NO16S 1052.6919 
  
SM3(d18:1) 16:0 C46H87NO16S 940.5667 
  22:0 C52H99NO16S 1024.6606 
  24:1 C54H101NO16S 1050.6763 
  
DHGM3    m/z [M-H] - 
DHGM3(d18:0) 16:0 C57H106N2O21 1153.7210 
  24:1 C65H120N2O21 1263.8305 
  
DHGM1    m/z [M-H] - 
DHGM1(d18:0) 16:0 C71H129N3O31 1518.8532 
  24:1 C79H143N3O31 1628.9627 
  
DHSialyl-LeX    m/z [M-H] - 
DHSialyl-LeX(d18:0) 16:0 C77H139N3O35 1664.9111 
  24:1 C85H153N3O35 1775.0206 
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Figure S 5.1: Total glycerophospholipid present in the core region of human lenses of different ages; (a) 
lyosophosphatidylethanolamine; (b) phosphatidic acid; (c) phosphatidylcholine. All values are expressed 
in nmol/g tissue wet weight. The solid line is a generalised additive model fit; the dashed lines give a 95% 
confidence band. The green line corresponds to the mean of the data and if the mean line is in between the 
95% confidence band, the null hypothesis of no change with age cannot be rejected. LPE: 
lysophospholipidethanolamine, PA: phosphatidic acid, PC: phosphatidylcholine. 
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Figure S 5.2: Total sphingolipid present in the core region of human lenses of different ages; (a) 
sphingomyelin; (b) dihydrosphingomyelin; (c) ceramide phosphate; and (d) dihydroceramidephosphate. 
All values are expressed in nmol/g tissue wet weight. The solid line is a generalised additive model fit; the 
dashed lines give a 95% confidence band. The green line corresponds to the mean of the data and if the 
mean line is in between the 95% confidence band, the null hypothesis of no change with age cannot be 
rejected. SM: sphingomyelin, DHSM: dihydrosphingomyelin, CerP: ceramide phosphate, DHCerP: 
dihydroceramidephosphate. 
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Figure S 5.3: Total glycosphingolipids present in the core region of human lenses of different ages; (a) 
sphingomyelin; (b) dihydrosphingomyelin; (c) ceramide; (d) dihydroceramide; (e) ceramide phosphate; (f) 
dihydroceramide phosphate. All values are expressed in nmol/g tissue wet weight. The solid line is a 
generalised additive model fit; the dashed lines give a 95% confidence band. The green line corresponds 
to the mean of the data and if the mean line is in between the 95% confidence band, the null hypothesis of 
no change with age cannot be rejected. DHLacCer: dihydrolactosylceramide, DHTriHexCer: 
dihydrotrihexosylceramide, ST: sulfatide, DHST: dihydrosulfatide, SM3: lactosylceramide sulfate, 
DHSM3: dihydrolactosylceramide sulfate. 
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Figure S 5.4: Total lipids present in the inner region of human lenses of different ages; (a) LPE; (b) PA; 
(c) PC; (d) CerP; (e) DHCerP; (f) DHLacCer; (g) DHTriHexCer. All values are expressed in nmol/g tissue 
wet weight. The solid line is a generalised additive model fit; the dashed lines give a 95% confidence band. 
The green line corresponds to the mean of the data and if the mean line is in between the 95% confidence 
band, the null hypothesis of no change with age cannot be rejected. LPE: lysophospholipidethanolamine, 
PA: phosphatidic acid, PC: phosphatidylcholineCerP: ceramide phosphateDHLacCer: 
dihydrolactosylceramide, DHTriHexCer: dihydrotrihexosylceramide. 
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Figure S 5.5: Total lipids present in the inner region of human lenses of different ages; (a) ST; (b) DHSM3; 
(c) DHGM3; (d) DHSialyl-Lex. All values are expressed in nmol/g tissue wet weight. The solid line is a 
generalised additive model fit; the dashed lines give a 95% confidence band. The green line corresponds 
to the mean of the data and if the mean line is in between the 95% confidence band, the null hypothesis of 
no change with age cannot be rejected. ST: sulfatide, DHSM3: dihydrolactosylceramide sulfate, DHGM3: 
dihydromonosialodihexosylganglioside, DHSialyl-Lex: dihydrosialyl Lewis acid. 
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Figure S 5.6:Total lipids present in the barrier region of human lenses of different ages; (a) LPE; (b) PA; 
(c) DHCERP; (d) DHLacCer; (e) DHTriHexCer; (f) DHGM3; (g) DHGM1, (h) DHSialyl-lex. All values 
are expressed in nmol/g tissue wet weight. The solid line is a generalised additive model fit; the dashed 
lines give a 95% confidence band. The green line corresponds to the mean of the data and if the mean line 
is in between the 95% confidence band, the null hypothesis of no change with age cannot be rejected. LPE: 
lysophospholipidethanolamine, PA: phosphatidic acid, DHCerP: dihydroceramidephosphate, DHLacCer: 
dihydrolactosylceramide, DHTriHexCer: dihydrotrihexosylceramide, DHGM3: 
dihydromonosialodihexosylganglioside, DHGM1: monosialotetrahexosylganglioside, DHSialyl-Lex: 
dihydrosialyl Lewis acid. 
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Figure S 5.7: Total lipids present in the outer region of human lenses of different ages; (a) LPE; (b) PE; 
(c) PA; (d) PC; (e) DHSM; (f) Cer; (g) CerP, (h) DHCerP. All values are expressed in nmol/g tissue wet 
weight. The solid line is a generalised additive model fit; the dashed lines give a 95% confidence band. The 
green line corresponds to the mean of the data and if the mean line is in between the 95% confidence band, 
the null hypothesis of no change with age cannot be rejected. LPE: lysophospholipidethanolamine, PE: 
phosphatidylethanolamine, PC: phosphatidylcholine, DHSM: dihydrosphingomyelin, Cer: ceramide, 
CerP: ceramide phosphate, DHCerP: dihydroceramidephosphate. 
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Figure S 5.8: Total glycosphingolipids present in the outer region of human lenses of different ages; (a) 
DHGM3; (b) DHGM1; (c) DHSialyl-Lex; (d) DHLacCer; (e) DHTriHexCer. All values are expressed in 
nmol/g tissue wet weight. The solid line is a generalised additive model fit; the dashed lines give a 95% 
confidence band. The green line corresponds to the mean of the data and if the mean line is in between the 
95% confidence band, the null hypothesis of no change with age cannot be rejected. DHGM3: 
dihydromonosialodihexosylganglioside, DHGM1: monosialotetrahexosylganglioside, DHSialyl-Lex: 
dihydrosialyl Lewis acid, DHLacCer: dihydrolactosylceramide, DHTriHexCer: 
dihydrotrihexosylceramide. 
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Chapter 6: Conclusions 
The work performed in this thesis focused on investigating the lipidome in each region of the human lens. 
Most of the lens lipid composition studies done to-date were based solely on whole lens homogenates or 
lenses split into cortical and nuclear regions only. In addition, most work has been completed on adult 
lenses, or lenses of a similar age. Deeley et al. observed changes to the lens DHSM distribution in the 
barrier region with age.1 Moreover, Hughes et al. reported significant increases in DHCer and Cer 
concentration in the nucleus of the human lens after the age of 40.2 Therefore, it is important that our study 
included all four regions of the lens, which develop at different stages across the lifespan and included 
lenses of different ages to observe any age-related changes. By applying MALDI-MS to human lens tissue 
sections and ESI-MS to lens lipid extracts, new insights into the distribution and composition of human 
lens lipids were revealed. 
The aims of this thesis were to study the distribution and age-related changes of lipids in the different 
regions of the human lens. This involved: 
i. Development and optimisation of MALDI imaging methods for the imaging of human lenses 
including tissue preparation and matrix application methods (Chapter 2) 
ii. Study of the distribution of sphingolipids in the human lens by MALDI-MS (Chapter 3) 
iii. Study of the distribution of phospholipids in the human lens by MALDI-MS (Chapter 4) 
iv. Quantification of age-related changes in lipid composition in four different regions of the lens, i.e. 
the outer, barrier, inner and core by ESI-MS (Chapter 5) 
In order to image human lens lipids, tissue preparation and matrix application methods were optimised and 
developed (Chapter 2). Previous studies involving the imaging of lipids in the human lens were limited,1, 3, 
4 as most of the studies were done on other animal lenses, which are larger in size than a human lens.5-7 
Furthermore, the lipid composition of the human lens is different to those of animals,8 which may require 
a different tissue preparation technique. The lens is also a very delicate tissue and tends to disintegrate 
during the process of slicing and mounting.6 Therefore, our study involved optimsing the mounting of tissue 
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onto a glass slide which plays a role in preserving the spatial resolution of the image. Although alternative 
landing techniques, such as ethanol-assisted soft landing were developed for the imaging of lens proteins,9, 
10 we have found that the soft landing of tissue directly on a glass slide and thaw-mounting the tissue with 
a finger pressed at the back of the glass slide to be the simplest and most effective way. For a tissue to 
undergo MALDI-MSI analysis, the application of a layer of homogenous matrix is essential. Previous 
MALDI-MSI studies of lens lipids have utilised ImagePrepTM or sublimation as the matrix application 
technique.1, 3 However, our work to develop a matrix application by ImagePrepTM has shown that it is not 
suitable for lens lipid analysis as it requires matrices that are soluble in a limited range of organic solvents. 
Furthermore, the ImagePrepTM matrix application technique produces large crystals and does not form a 
homogeneous layer of matrix, resulting in poor spatial resolution. Sublimation was also tested as it requires 
a shorter preparation time (~15 mins) compared to the ImagePrep™ method (~90 mins) and produces a 
more homogeneous layer of crystals. Previous studies used CHCA3 or DHB1 as the matrix for lipid imaging 
but no GSLs were imaged. As the range of lipids we have imaged involved many GSLs in the higher mass 
range, we tested other matrices such as MBT and DAN in different ion modes in order to image the highest 
number of lipid species possible. This thesis demonstrated that sublimation is the best matrix application 
method for human lenses, with MBT and DAN being the most suitable matrices for lipid imaging in positive 
and negative ion modes, respectively. 
This thesis utilised MALDI-MS to map the spatial distribution of recently identified sphingolipids in the 
adult human lens (Chapter 3). While numerous classes of  SLs and GSLs have been identified in the human 
lens11-16 an understanding of their distribution across the different regions of the lens is limited.17  In this 
chapter, the distribution of many sphingolipids was revealed for the first time in the adult lens and we have 
observed that certain sphingolipids are only present in specific lens regions. For example, DHST and ST 
are only present in the cortex, not the nucleus, whilst DHLacCer, Cer and DHCer are found in the nucleus 
and are absent in the cortex. The different distribution of various sphingolipids in the adult human lens 
raises intriguing questions as to the role of these lipids within the human lens.  
This thesis also determined the distribution of GPs in the adult human lens, including PA that was imaged 
for the first time in the adult human lens (Chapter 4). The majority of GPs such as PE, PS and PA were 
found to be mainly present around the cortex, except for LPE, which is present in the nucleus. Combining 
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these data with the previous chapter, we have now gained spatial information for most of the lipids identified 
to-date in the human lens.  
Quantification of the lipids in different regions of the human lens was also undertaken in this thesis (Chapter 
5). Previous quantification of lens lipids in the core region of human lens published by Hughes et al. only 
included GPs and four classes of SLs.2 In our study, we have included the quantification of 15 classes of 
SLs and GSLs. Previous studies that have quantified human lens lipids were only performed on whole 
lenses, or lens nuclear and cortical regions.2, 8, 18, 19 As the lens nucleus is synthesised before birth and has 
no lipid turnover,20 its lipid composition can be very different from the cortex, particularly with the 
development of the barrier region around middle age.21, 22 Our data from previous imaging experiments 
(Chapter 3 and 4) have also shown that lipids can have very different distributions in the lens, thus it is 
important to quantify lipids in each region of the lens.  Our data has shown that the lipid composition in 
each region of the lens can vary. For example, the lens core and inner region have a higher percentage of 
SL in comparison to the barrier and outer regions, whereas GPs were most abundant in the outer region and 
lowest in concentration in the core. Many events occur around middle age (40-45) in the lens such as the 
formation of a barrier to the diffusion of antioxidants,21, 22 an increase in lens stiffness and presbyopia,23-25 
a sudden increase in Cer and DHCer levels2 and the increase of cation permeability26.  Thus, it is also 
essential that age-related changes to the lens lipid composition be studied in detail across all regions of the 
lens. We have observed that some lipids like PA and DHLacCer did not show any age-related changes in 
all regions. For those that did, GP levels decreased with age while SL levels increased with age in all 
regions. The sudden increase in DHCer levels around the age of 40 also occurs in all regions. Another 
interesting finding is that the barrier has the most lipid classes that were altered in abundance with age.  
The lens is a unique model for studying age-related changes in the human body as it contains both old and 
new fibre cells that were synthesised throughout a human’s lifespan. This thesis showed that lens lipids 
were localised to specific regions of the lens. Each region was composed of a different lipid composition 
and it was shown that ageing can affect the abundance of lipids in the region. This is important, particularly 
as the unique composition of the lens lipid bilayer is vital in various homeostatic functions such as resisting 
oxidation27 and regulating water permeability.28 As the biosynthesis of fatty acids and cholesterol in the 
lens does not appear to change significantly throughout a human’s lifespan,29 our observation of the relative 
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increase in SL levels and the decrease of PL levels in the lens nucleus may be the consequence of non-
enzymatic degradation. Our observations of lipid changes around middle age matches with previous 
identification of a key transition point where changes in lipid composition and also lens stiffness were 
observed.20, 23 It was hypothesised by Borchman et al. that during one’s lifespan, a threshold of lipid 
oxidation may be exceeded that causes a cascade of lipid and protein changes, leading to age-related nuclear 
cataract.30  
The imaging and quantification studies done in this thesis are aimed to complement each other so that a 
thorough overview of changes in distribution and abundance of lipids with age can be investigated. Our 
results comparing the images obtained in Chapter 3 and 4 with the abundance data in Chapter 5 have shown 
that the results obtained with ESI-MS matched with the results obtained with MALDI-MSI. For example, 
DHSM showed an annular distribution around the nucleus region for a lens of 51-year old. Quantification 
studies also showed that DHSM has the highest abundance in the barrier region around the age of 51. 
However, there were limited samples used in the imaging studies, where only lenses older than the age of 
40 were imaged. As mentioned, middle age is the key transition point for changes to occur in the lens, 
therefore, future work may aim to image lenses of different ages to see if their distribution changes matches 
with the results observed in Chapter 5. This thesis showed that MALDI-MSI may be used as a quick analysis 
tool to study the changes of lipids in the lens with age. Methods of obtaining absolute abundance of a lipid 
directly off a tissue slice without the need of lengthy extraction and quantification procedure may be 
developed in the future for more efficient analysis. As mentioned in Chapter 5, some gangliosides such as 
GD1a were not detected or quantified in this study. Therefore, more work is required to fully elucidate and 
quantify the GSLs in the lens. A previous study by Friedrich and Truscott found that with age, denatured 
crystallins interact with fibre cell membranes.31 However, studies of this nature show the effect of increased 
protein on protein-lipid interaction instead of investigating the effect of increased lipid on protein-lipid 
interaction. It is unknown whether alterations in membrane lipids alters lens function, or if lipids are 
increased as a consequence of other ageing processes in the lens. The information of lens lipid alteration 
with age can be combined with the information of lens protein or other age-related lens studies to see if 
there is any link between the changes in lipid composition with other age-related changes in the lens. This 
may perhaps help to understand their role in the human lens and if they are involved in the enzymatic 
activities in the outer region of the lens, or play a role in anti-oxidation or anti-ageing in the lens nucleus.  
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